A study to compare the effectiveness of oral honey application and chlorhexidine mouth wash in healing oral mucositis due to chemo and radiation among cancer Patients in a selected hospital at Kanyakumari district by Berlin Rajan, M
A STUDY TO COMPARE THE EFFECTIVENESS OF ORAL HONEY 
APPLICATION AND CHLORHEXIDINE MOUTH WASH IN 
HEALING ORAL MUCOSITIS DUE TO  CHEMO  
AND RADIATION AMONG  CANCER  
PATIENTS IN A SELECTED HOSPITAL  
AT KANYAKUMARI DISTRICT 
 
 
 
 
 
 
 
 
 
DISSERTATION SUBMITTED TO 
 
 
THE TAMILNADU  DR. M.G.R. MEDICAL UNIVERSITYCHENNAI 
IN PARTIAL FULFILLMENT OF REQUIREMENT FOR THE 
AWARD OF DEGREE OFMASTER OF  
SCIENCE IN NURSING 
OCTOBER- 2014 
A STUDY TO COMPARE THE EFFECTIVENESS OF ORAL HONEY 
APPLICATION AND CHLORHEXIDINE MOUTH WASH IN 
HEALING ORAL MUCOSITIS DUE TO  CHEMO  
AND RADIATION AMONG  CANCER  
PATIENTS IN A SELECTED HOSPITAL  
AT KANYAKUMARI DISTRICT 
 
2013- 2014 
 
Certified that this is the bonafied work of  
 
Mr. BERLIN RAJAN .M 
II
nd
 year M.Sc Nursing 2012-2014 
Global College of Nursing,  Edavilagam, 
Nattalam, Marthandam, 
KanyakumariDistrict . 
 
COLLEGE  SEAL 
 
SIGNATURE:    -------------------------- 
                                    Prof. Mrs. A. MAHIZH. M.Sc.(N) 
                                          Principal, Global College of Nursing,   
                                         Edavilagam, nattalam, marthandam, 
                                          Kanyakumari District 
 
 
Dissertation Submitted to 
THE  TAMIL NADU  DR. M.G.R. MEDICAL  UNIVERSITY, 
CHENNAI 
In partial fulfillment of requirement for the award of degree of 
MASTER OF SCIENCE IN NURSING, OCTOBER- 2014 
A STUDY TO COMPARE THE EFFECTIVENESS OF ORAL HONEY 
APPLICATION AND CHLORHEXIDINE MOUTH WASH IN 
HEALING ORAL MUCOSITIS DUE TO  CHEMO  
AND RADIATION AMONG  CANCER  
PATIENTS IN A SELECTED HOSPITAL  
AT KANYAKUMARI DISTRICT 
 
2013- 2014 
Approved  by  Dissertation committee in 2012 
PROFESSOR IN NURSING RESEARCH  
 
Prof.Mrs. A. MAHIZH. M.Sc(N)             ---------------------------------- 
Principal ,Global College of Nursing,   
Edavilagam, Nattalam, Marthandam, 
KanyakumariDistrict . 
 
CLINICAL SPECIALITY EXPERT  
 
Mrs. REGILA JASMINE. M.Sc(N)               ---------------------------------- 
Lecturer, Medical Surgical Nursing,   
Global College of Nursing, Edavilagam, Nattalam, Marthandam, 
Kanyakumaridistrict . 
 
MEDICAL EXPERT     
 
Dr. V.G.SUDHAKARAN, B. Sc, MBBS, MD, DMRT --------------------------------
--Head Of Department- Oncology,  
International Cancer Center, 
Neyyoor, Kanyakumari District. 
 
 
 
Dissertation Submitted to 
THE TAMIL NADU DR. M.G.R. MEDICAL  UNIVERSITY CHENNAI 
IN PARTIAL FULFILLMENT OF REDUIREMENT FOR THE 
AWARD OF DEGREE OFMASTER OF SCIENCE IN NURSING,  
OCTOBER- 2014 
A STUDY TO COMPARE THE EFFECTIVENESS OF ORAL HONEY 
APPLICATION AND CHLORHEXIDINE MOUTH WASH IN 
HEALING ORAL MUCOSITIS DUE TO  CHEMO  
AND RADIATION AMONG  CANCER  
PATIENTS IN A SELECTED HOSPITAL  
AT KANYAKUMARI DISTRICT 
 
 
 
 
 
Internal Examiner                                                                 External Examiner 
 
 
 
 
 
 
 
 
 
SUBMITTED      
THE TAMIL NADU DR. M.G.R MEDICAL UNIVERSITY, CHENNAI. 
 IN PARTIAL FULFILLMENT OF THE REQUIREMENT FOR THE  
DEGREE OF MASTER OF SCIENCE IN NURSING,     
 
                                                    OCTOBER- 2014 
                                                   
CERTIFICATE 
 
This is to certify that the dissertation entitled,“A study to compare 
the effects of oral honey application and chlorhexidine mouth wash in 
healing oral mucositis among cancer patients due to chemo and 
radiation in the selected hospital at Kanyakumari district” is a bonafide  
work done byMr.M.Berlin Rajan, II M.Sc (N), Global College of Nursing, 
Nattalam in partial fulfillment of  the University rules and regulations for 
the award of M.Sc (N) degree under my guidance and supervision  during 
the academic year October 2012-2014. 
 
 
 
Name and Signature of the guide  :     ---------------------------------------------- 
   Prof. Mrs. MAHIZH . M.Sc (N) 
Date with Seal : 
 
 
 
Name and Signature of the Head of Department   :    ----------------------------------                                      
 Mrs. REJILA JASMINE, M.Sc (N) 
Date : 
 
 
 
 
                                     ACKNOWLEDGEMENT 
 
I wish to acknowledge my heartfelt gratitude to the Lord Almighty 
for all the wisdom, knowledge, guidance, strength, protection, shield and 
support throughout the conduction until the successful completion of the 
study. He has offered me throughout this endeavor and given me courage to 
overcome the difficulties and thus to complete this study successfully. 
 I honestly express my sincere gratitude to all the study participants 
who extended their co-operation throughout my study period. 
 I am extremely grateful the chairman Dr. Sam .G. JebaJoslin and 
the secretary Mrs.  Sakhila Santhakumari, MA., M.Phil,  of  Global 
College of Nursing for giving me an opportunity to study in this esteemed 
institution and supporting me in all the ways and means to complete this 
study. 
I extend my gratitude and sincere thanks to Prof. Mrs. A. Mahizh, 
M.Sc. (N)., Principal, Global College of Nursing, Nattalam, for her 
invaluable guidance, continued support, promising criticisms, suggestions 
and concern during the entire course of this dissertation. 
I extend my gratitude and sincere thanks to Prof. Mrs. Jemila 
Davidson, M.Sc.(N).,Vice-Principal, Global College of Nursing,for her 
invaluable guidance, continued support, expert suggestions, kind co-
operation,  encouragement and round the clock support which helped me in 
completion of this dissertation. 
I extent my gratitude to Mrs. Regila Jasmine, M.Sc (N); Lecture 
HOD of Medical Surgical Nursing, Global College of Nursing who has 
guided as a good mentor and for her valuable suggestions, motivation and 
guidance throughout this dissertation. 
I am very much thankful to my most respectful Class Coordinator                                 
Mrs.Vimala, M.Sc (N)., Lecturer, for her expert guidance and valuable 
suggestion for completing the study. 
              I am pleased to convey my profound thanks to Dr. S. RAJESH 
SATHYA, MBBS., MD., D.A.A.D.N.B and Dr. V.G. SUDHAKARAN, 
B.Sc.,MBBS.,MD., DMRT., From International Cancer Center at Neyyoor, 
who allowed to conduct this study and to complete this study. For their 
excellent guidance, expert suggestions, encouragement and support that 
helped me to tide over the hardships encountered during the study. 
               I am very much obliged to Mr. Anto, MSc., M.Ed., M.Phil., 
PGDBS., Biostatistician Global College of Nursing, for his guidance in the 
statistical analysis of data in this study. 
I am grateful to Mini Internet Cafe for having patiently deciphered 
and manuscripts into a legible piece of work. 
My immense thanks to Librarian of Global College of Nursing and 
the library of The TamilnaduDr.MGR Medical University, Chennai for 
having accessed me to procure the required literature review for the conduct 
of this study. 
 
My heartfelt thanks to all Teaching and Non-Teaching Staff of 
Global College of Nursing for their constant help and encouragement 
throughout my study. 
I take this golden opportunity to thank my beloved parents and 
brother who have been the foundation for my success in my educational 
endeavor.  
 
         
       BERLIN RAJAN.M 
 
 
 
 
ABSTRACT 
 “The most important thing in illness is never to lose heart” 
                                                               -Nikolai Lenin 
Introduction: 
Most patients with cancer experience oral mucositis during 
chemotherapy and radiation therapy. Ignoring this oral mucositis can 
contribute to worsening overall health of patients and slowed recovery 
process. 
 
Objectives of the Study 
1) To assess the  level of  oral mucositis  due to chemo /radiation therapy  
in patient with  cancer among Groups 1 and 2. 
2) To assess the post test level of  oral mucositis after oral application of 
honey for group 1  and chlorhexidine mouth wash  for group 2. 
3) To assess the effect of oral honey application in healing oral mucositis 
due to chemo/radiation by comparing the pre and post test scores within 
group 1. 
4) To assess the effect of chlorhexidine mouth wash in healing oral 
mucositis due to chemo/radiation by comparing the pre and post test 
scores within group 1. 
5) To compare the effects of oral honey application and chlorhexidine  
mouth wash in healing  oral mucositis due to chemo/radiation 
6) To determine the association between  the pretest level of oral mucositis 
due to  chemo/radiation among groups 1 and 2 and their selected 
demographic variables such as  age, gender, frequency of mouth wash, 
personal habits, duration of illness, stages of  cancer, received 
chemotherapy, received radiation therapy 
The investigator adopted General System Theory as the conceptual 
framework for the study. Quasi experimental with time series pre testpost 
test design was used and the formal consent was obtained from International 
Cancer Center, Neyyoor and the investigator selected 60 samples using 
purposive sampling technique and who are fulfilling the inclusive criteria 
were selected as a samples both in group 1 and group 2. 
Descriptive and inferential statistics were used to analyze the data. 
Analysis of demographic variables was done in terms of frequency and 
percentage distribution. Comparison of post test level of oral mucositis 
between the group 1 and group 2 was analysedby ‘t’ test. Which is an 
inferential statistical analysis. Association of post test level of oral 
mucositis in the group 1 and group 2 with demographic variables was 
analysed by using chi-square test.  
 The findings concluded that in the group 1, 17(57%) of them had 
Grade 3 level oral mucositis, 13(43%) had Grade 4 level of oral mucositis 
in their pre-test assessment. Whereas in the post-test 20(67%) of them had 
Grade 0, 10(33%) had Grade 1 level of oral mucositis. 
The findings concluded that in the group 2, 20(67%) of them had 
Grade 3 level oral mucositis, 10(33%) had Grade 4 level of oral mucositis 
in their pre-test assessment. Whereas in the post-test 11(37%) of them had 
Grade 0, 19(63%) had Grade 1 level of oral mucositis. 
It revealed that among group 1 the mean pre-test score was 3.5 with 
standard deviation with 0.489. The mean post-test was 0.3 with standard 
deviation 0.447. The mean difference was 3.2. The obtained ‘t’ value was 
2.68, where as the table value was 2.04. It was significant at p< 0.05 level. 
It revealed that among group 2 the mean pre-test score was 3.6 with 
standard deviation with 0.465. The mean post-test was 0.6 with standard 
deviation 0.474. The mean difference was 3.0. The obtained ‘t’ value was 
2.65, where as the table value was 2.04. It was significant at p< 0.05 level. 
Hence it was inferred that  the oral honey application and 
chlorhexidine mouth wash was equally effective in healing oral mucositis 
among clients with cancer.  
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CHAPTER I 
INTRODUCTION 
“Life is not measured by the breaths we take, but rather by the 
moments that take our breath away.” 
   -Hilary Cooper 
 There are over 20 million people living with cancer in the world 
today. The estimate number of cases each year is expected to increase from 
2 million in 2000 to 15 million in 2020. The number of cancer deaths 
annually will increase from about 6 million to l0 million. Cancer has now 
become the third leading cause of deaths in Asian countries. In India, there 
are approximately 2.2 million cases of cancer and around 7,00,000 new 
cases are being detected each year.Among Indian women cancer in the 
breast account for nearly 60 percent of all cancers. Several studies reported 
that head and neck cancer is proportionately on the increase in a 
metropolitan area of India. 
 Cancer, as a malignant neoplasm, is a broad group of various 
diseases, all involving unregulated cell growth. In cancer, cells divide and 
grow uncontrollably, forming malignant tumours, and invade nearby parts 
of the body. The cancer may also spread to more distant parts of the body 
through the lymphatic system or bloodstream. Not all tumours are 
cancerous. There are over 200 different known cancers that afflict humans. 
 Cancer is one of the leading causes of death around the world.  It is 
estimated that around 84 million people died of cancer between 2005 and 
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2015 without intervention. Low income and medium income countries are 
harder hit by cancer than the developed countries. It is essential to address 
the world‟s growing cancer burden and effective control measures to 
minimise the risk. 
 The worldwide cancer incidence rate is estimated as seven million 
with the annual mortality of about five millions.  It is projected, by the year 
2015, nearly 2/3 of all cancer causes severe life threatening problems in the 
developing countries alone. Cancer is estimated to account for almost 6% of 
the entire global burden of the disease
. 
Chemotherapy and radiation therapy are the most widely used 
interventions for the treatment of cancer. Although these treatments are 
employed to improve the patient's quality of life, they are associated with 
several side effects
. 
Annually, there are approximately 400,000 cases of 
treatment-induced damage to the oral cavity. Children and adolescents 
make up a unique group of patients in a cancer setting and are at increased 
risk of oral mucositis. 
Cancer patients undergoing chemotherapy usually become 
symptomatic four to five days after beginning treatment, reaching a peak at 
around day 10, and then slowly improving over the course of a few weeks. 
Mucositis associated with radiotherapy usually appears at the end of the 
second week of treatment and may last for six to eight weeks
.
As a result of 
cell death in reaction to chemo- or radio-therapy, the mucosal lining of the 
mouth becomes thin, may slough off and then become red, inflamed and 
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ulcerated. The ulcers may become covered by a yellowish white fibrin clot 
called a pseudo membrane
. 
Chemotherapy is the specific treatment of cancer, where the specific 
antineoplastic agents are used. These agents interfere with the cellular 
function, including replication. It is used primarily to treat the systemic 
disease. It may be combined with surgery, radiation therapy, or both. 
Repeated dose of chemotherapy are necessary over a prolonged period. 
The concept of perfect positive health cannot become a reality 
because man will never be so perfectly adapted to his environment that his 
life will not involve struggles; failures and sufferings. Positive health will 
therefore, always remain mirages, because everything in our life is subject 
to change .Health in this context has been described as a potentiality - the 
ability of an individual to modify him or itself continually in the face of 
changing conditions of life. 
Interest in complementary alternative medicine has grown 
dramatically over the past several years. According to survey results 80% of 
patients repeated using some type of complementary alternative medicine, 
in that 54 % took herbal products and 30 % used relaxation techniques. 
Direct Mucositis - The epithelial cells of the oral mucosa undergo 
rapid turnover, usually every 7 to 14 days, which makes these cells 
susceptible to the effects of cytotoxic therapy. Both chemotherapy and 
radiation therapy can interfere with the maturity and cellular growth of 
epithelial cells, causing changes to normal turnover and cell death. 
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Indirect Mucositis - Oral mucositis can also be caused by the indirect 
invasion of gram-negative bacteria and fungal species. Patients are at 
increased risk for oral infections when they are neutropenic, and this usually 
happens when indirect stomatotoxicity appears. The onset of mucositis 
secondary to myelo suppression varies, depending upon the timing of the 
neutrophil count associated with the chemotherapy agent administered, but 
typically develops anywhere from 10 to 21 days after chemotherapy 
administration. 
Oral mucositis is a painful inflammation and ulceration of mucous 
membranes of the oral cavity. It is a common side effect of most 
chemotherapeutic drugs, and radiotherapy of the oral, and head and neck 
cancers. In addition to impacting the quality of life of cancer patients, it 
influences treatment decisions, often requiring reductions of dose and 
delays or even discontinuation of therapy resulting in tumor rebound and 
cancer relapse. Mucositis-related ulcers are also prone to infections, which 
may be life-threatening and may exacerbate underlying oral, gum, dental, 
andperiodontal problems. Oral mucositis is a debilitating complication 
commonly seen in 25% to 33% of cancer patients treated with 
chemotherapy; and nearly 100% in those Treated with high-dose 
myeloablative chemotherapy before undergoing bone marrow 
transplantation  (BMT). 
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NEED FOR THE STUDY 
Districts in the central, south, northeast India have the world‟s 
highest incidence of cancer associated with tobacco in India. Aizawl district 
in the northeast state of Mizoram has the world‟s highest incidence of lower 
pharynx cancer (11.5 per 1,00,000 people) and  tongue cancer (7.6 per 
1,00,000 people) in men and also highest in stomach cancer wardha, 
Madhya Pradesh has the highest incidence of mouth ulcer in the world. Rate 
of stomach cancer were high among men in Bangalore, Chennai and also 
detected highest incidence in women in coastal district, Kerala, Karnataka 
and Goa. Lung cancer is the most common cancer in men in Calcutta, 
Mumbai and New Delhi.  
(Population Based Cancer Registries, 2001) 
The results of two clinical trials evaluating palifermin for reducing 
theseverity of oral mucositis in patients undergoing chemo andradiotherapy 
for head and neck cancer were published in 2011. The results of those trials 
are encouraging, as both studies were well-designed randomized controlled 
trials. Both trials evaluated whether the use of palifermin can reduce the 
frequency and severity of grade 3 and grade4 oral mucositis (as defined by 
World Health Organization criteria) in patients receiving cisplatin plus 
concurrent radiotherapy for head and neck cancer. The two trials each 
enrolled almost 190 patients (just under 95 patients per treatment or placebo 
group), which provided enough power (≥90%) to detect a reduction of 25% 
in the combined rate of grade 3 and grade 4 oral mucositis with a two-sided 
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alpha value of 5%. The primary endpoint in both studies was the cumulative 
frequency of grade 3 and grade 4 oral mucositis. Secondary endpoints 
included the duration and time to onset of mucositis, opioid analgesic use 
(cumulative dose), and the frequency of chemotherapy treatment delays and 
radiotherapy. (Edward Li, James A, 2012) 
Prevalence rate of oral mucositis in cancer patients have been 
estimated up to 40% in patients receiving standard dose chemotherapy, 90% 
in head and neck cancer patients subjected to chemo-radiotherapy and 90% 
in patients undergoing high dose myeloablative chemotherapy for 
hematopoietic stem cell transplant. Oral mucositis is a complex process of 
biologic phenomena primarily related to the type and dosage of cancer 
therapy, oral mucositis is usually observed three to five days after initiation 
of chemotherapy. Chemotherapy induced oral mucositis reaches peak 
intensity at 7-14 days and slowly resolves unless complicated by infection 
or repeated drug administration. 
Studies have shown that an oral care protocol (tooth brushing, 
chlorhexidine rinse [0.2%], and saline) resulted in a 38% reduction in 
incidence and a significant reduction in severity and associated oral pain in 
pediatric patients with cancer. Ice chipsor saline mouth rinse may lessen the 
severity or help prevent symptoms of mucositis or mouth sores in patients 
receiving melphalan and autologous stem cell transplant for multiple 
myeloma. It is not yet known whether ice chips are more effective than 
saline mouth rinse in reducing or preventing mucositis. 
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Oral mucositis is a significant problem in patients 
undergoingchemotherapeutic   management for solid tumors. In one study it 
was reported that 303 of 599 patient (50%) receiving chemotherapy for 
solid tumor or lymphoma developed oral mucositis or GI mucositis in 22% 
of 1236 cycles of chemotherapy. GI mucositis in 7% of cycles. An even 
higher percentage (approximately 75-80%) of patient who receive high dose 
chemotherapy prior of hemopoietic cell transplantation develop clinically 
significant oral mucositis. (Rajesh. V. Lalla, 2008). 
 Dry mouth and distorted taste were reported by 63 (72%) and 55 
(63%)subjects separately. The 55% and 40% subject reported having weight 
loss and dysphagia respectively. The mean intensity and the distress score 
of oral mucositis and oral dysfunction reported by the subjects ranged from 
1.96 to 2.51 and 1.58 to 1.09 respectively. (Shatin, 2007). 
 This comparative study is carried out on a sample of 15 non-smoking 
patients with chronic periodontitis at the Department of Periodontology, the 
International University  of  Catalunya, Barcelona, Spain. All patients used 
either 0.2% chlorhexidine Mouthwash  (control group =bottle B) or 
chlorhexidine with ADS (test group=bottle A) For  15 days. Each patient 
first rinsed with a randomly assigned mouthwash for 15 days followed by a 
15-day washout period. Subsequently, each patient used a second 
mouthwash. Before each cycle, a full dental prophylaxis was performed. 
The plaque, gingival, and Brecx staining indexes were used,The result 
showed less tooth staining with test group (P<0.01). No statistically 
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significant differences were observed in plaque (P =0.1496) and gingival 
indexes(P =0.1688). Eighty-eight percent of patients followed the 
instructions outlined in the protocol. In terms of other adverse effects, two 
patients reported a bad taste with both mouthwashes.(Solis C, Santos A. 
2011) 
 
STATEMENT OF THE PROBLEM 
        A study to compare the effects of oral honey application and 
chlorhexidinemouth wash in healing of oral mucositis due to chemo and 
radiation among cancer patients in the selected hospital at Kanyakumari 
district. 
 
OBJECTIVES 
1. To assess the  level of  oral mucositis  due to chemo /radiation 
therapy  in patient with cancer among Groups 1 and 2. 
2. To assess the post test level of  oral mucositis after oral application 
of honey for group 1 and chlorhexidine mouth wash  for group 2. 
3. To assess the effect of oral honey application in healing oral 
mucositis due to chemo/radiation by comparing the pre and post test 
scores within group 1. 
4. To assess the effect of chlorhexidine mouth wash in healing oral 
mucositis due to chemo/radiation by comparing the pre and post test 
scores within group 1. 
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5. To compare the effects of oral honey application and chlorhexidine  
mouth wash in healing oral mucositis due to chemo/radiation 
6. To determine the association between  the pretest level of oral 
mucositis due to chemo/radiation among groups 1 and 2 and their 
selected demographic variables such as age, gender, frequency of 
mouth wash, personal habits, duration of illness, stages of cancer, 
received chemotherapy, received radiation therapy. 
 
HYPOTHESES: 
 The following hypotheses are formulated for the study and were 
tested at 0.05 level of significance. 
 H1: There is a significant difference between pre and post test 
levels of oral mucositis.  In group 1 and 2 
 H2: There is a significant difference between the post tests levels of 
oral mucositis.Among the group 1 and 2. 
H3: There is a significant association of the pre tests levels of oral 
mucositis in group1and 2 With the selected demographic variables such as 
age, gender, frequency of mouth wash, personal habits, duration of illness, 
stages of cancer, received chemotherapy, received radiation therapy.    
 
ASSUMPTIONS 
1. All the cancer patients receiving chemo and radiation therapy may 
develop oral mucositis as side effects. 
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2. Honey application and chlorhexidine mouth wash may have positive 
effects of healing oral mucositis due to chemo/radiation. 
3. Oral honey application and chlorhexidine mouth wash may differ in 
their.  Healing effects on oral mucositis due to chemo/radiation. 
 
DELIMITATION OF THE STUDY: 
      This study was delimited to 
 Only 60 samples 
 Only one hospital (oncology) 
 Only 4 weaks for data collection 
 Only cancer patients on chemo/radiation therapy 
 Only patients with cancer at 2nd ,3rd, or 4th stage 
 Only cancer patients receiving chemo/Radiation from 2nd cycle 
 
OPERATIONAL DEFINITION 
1.EFFECTS 
In this study effect refers to the positive outcome of honey 
application in oral cavity and chlorhexidine mouth wash in complete 
healing of oral mucositis among cancer patients.  
 
2.ORAL HONEY APPLICATION 
In this study it refers to introducing 5 ml of pure honey into the oral 
cavity and asking the client to hold it for 30 seconds until it spread over and 
then to swallow it, thus it is done four times a day for four days. 
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3.CHLORHEXIDINE MOUTH WASH 
In this study refers to rinsing mouth and oral cavity with 10 ml 
of0.2% chlorhexidine  solution for 30 seconds for four times a day for four 
days. 
 
4.HEALING 
In this study it refers to complete disappearance of the infected cells 
or mucous layer  in  the oral cavity especially on the tongue. 
 
5.ORAL MUCOSITIS 
In this study it refers to inflammation of the cells coating the oral 
cavity and tongue producing whitish or reddish patches and sores over the 
tongue and oral cavity causing pain, swallowing, swallowing and speech 
difficulty and loss of appetite. 
 
6.CANCER PATIENTS 
In this study cancer patient refers to the person diagnosed to have 2
nd
 
or 3
rd
 or 4
th
 stage of a disease with abnormal proliferation of cells in any 
body organ or in blood. 
 
7.CHEMO AND RADIATION THERAPY 
In this study it refers to a kind of therapeutic measure done for have 
2
nd
 or 3
rd
 or 4
th
 stage of cancer in which certain cancer cells killing drugs are 
given to and anticancer rays are passed to the affected areas of such 
patients.  
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CONCEPTUAL FRAMEWORK 
GENERAL SYSTEM THEORY (LUDWIG VON BETTENLAFFY-1968) 
Tabot (1995) defined conceptual framework a network of 
interrelated changes that provide a structure for organizing and describing 
the framework that facilitates visualizing the problem and places the 
variables in the logical manner. 
 All system is open in that there is a continual exchange of matter, 
energy and intervention. There are three components; 
 Input 
 Throughput 
 Output 
 
Input 
The information that enters into the system from the environment 
through its boundaries. 
In this study input is the pre assessment on level of oral mucositis by 
using WHO Oral Toxicity Scale among groups 1 and 2 and their 
demographic variables that could have indirectly contributed to the 
problem. 
 
Throughput  
Is the operation phase ie, it is the process that allows the input to be 
changed as output in such a way that it can be readily used by the system. 
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In this study during the activity phase the investigator administered 
oral honey application to group 1 introducing 5 ml of pure honey into the 
oral cavity and asking the client to hold it for 30 seconds until it spreads 
over and then swallowing it, thus it is done four times a day for four days 
and to group 2 chlorhexidine mouth wash was done by rinsing mouth and 
oral cavity with 10 ml of 0.2% chlorhexidine solution for 30 seconds for 
four times a day for four days. 
 
Output  
Post test was done with the same scale among both the groups and 
was detected using same WHO Oral Toxicity Scale. 
 
Feedback  
It emphasis to strengthen the input and throughput and it was 
necessary if the output show no reduction in level of oral mucositis in the 
both groups. 
In this study, the post tests level of oral mucositis was found to be 
significantly reduced among both the groups and a difference was shown 
between the post tests level of oral mucositis and hence feedback was not 
necessitated.  
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 Group 2 
 
  
 
  Feedback
INPUT THROUGHPUT OUTPUT 
DEMOGRAPHIC        
VARIABLES 
i)Age  
ii) Sex 
iii)Frequency of 
mouth wash 
iv) Personal habits 
v) Stages of cancer 
vi)Received 
chemotherapy 
vii)Received 
radiation therapy 
viii)Duration of 
illness 
PRE TEST 
Level of oral 
mucositis 
 By using WHO 
Oral Toxicity 
Scoring:  
Grade 0- 
 None 
Grade 1- 
Soreness 
erythema 
Grade 2- 
Erythema ulcer 
can eat solids 
Grade 3- Ulcer 
liquid diet only 
Grade 4- 
Alimentation 
not possible 
 
 
 
Group 1 
Group 2 
ORAL HONEY 
APPLICATION 
    Introducing 5 ml of 
pure honey into the 
oral cavity and 
asking the client to 
hold in for 30 seconds 
until it spread over 
than swallowing it 
thus it is done four 
times a day for four 
days  
CHLORHEXIDINE 
MOUTH WASH 
       Rinsing mouth and 
oral cavity with 10 ml of 
0.2% chlorhexidine 
solution for 30 seconds 
for four times a day for 
four days  
 POST TEST 
Level of oral 
mucositis 
 By using WHO 
Oral Toxicity 
Scale  
Scoring:  
Grade 0- 
 None 
Grade 1- 
Soreness 
erythema 
Grade 2- 
Erythema ulcer 
can eat solids 
Grade 3- Ulcer 
liquid diet only 
Grade 4- 
Alimentation 
not possible 
 
 
 
Honey 
application
effective 
No changes 
Chlorhexidine 
mouth wash 
effective 
No changes 
Group 1 
FIGURE 1.1 
Conceptual frame work based on Modified General System Theory (Ludwig von Bertalanffy – 1968) 
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CHAPTER II 
REVIEW OF LITERATURE 
The literature review involves the systematic identification, location, 
scrutiny and summary of written materials that contain information of a 
research problem (Polit and Hungler 2004). 
A review of literature is a key step in research process and it refers to 
extensive, exhaustive and systemic examination of publications relevant to 
research project. The researcher presents the review of literature for the 
present study under the following headings. 
1. Studies related to incidence of oral mucositis due to chemo and              
Radiation therapies in cancer patients 
2. Studies related to healing of chemo and radiation related oral 
Mucositis with honey application. 
3. Studies related to healing of chemo/radiation related oral mucositis 
With chlorhexidine mouth wash. 
4. Studies related to comparison of effects of other medications and 
Chlorhexidine mouth wash in healing chemo/radiation related oral 
mucositis 
 
1. Studies related to incidence of oral mucositis due to chemo and 
Radiation therapies in cancer patients. 
Oral mucositis is a common and significant problem of cancer 
chemotherapy, especially patients who receives high-dose therapy. Two 
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recently published retrospective analyses of patient complaints following 
chemotherapy have identified oral mucositis as the worst toxicity reported 
by patients, and what is more important is that patients indicated that 
oncology healthcare team members do a poor job of managing and 
providing methods of symptom relief. Twenty percent of patients surveyed 
indicated that they received no symptom relief at all (Ronald., 2005). 
A prospective observational study was conducted to examine the 
burden of mucositis and risk of complications in head and neck cancer 
patients receiving radiation with or without chemotherapy. Oral mucositis 
was assessed at the end of two, four and six weeks by using questionnaire 
for head and neck cancer. A 12 team instrument was used to measure mouth 
and throat soreness and pain and limitation in oral functions. Data were 
collected at every week and results showed that oral mucositis had initially 
developed for who with radiation therapy and severe mucositis and throat 
soreness occurred in 76 percent of patients (Bjarnason, G.,2005). 
A descriptive study was conducted to find out the incidence of oral 
mucositis in cancer treatment. Patients receiving radiation therapy and 
chemotherapy were included in the study. Patients oral cavity was assessed 
weekly and identified that patients receiving chemotherapy oral mucositis 
usually develop from 10 to 12 days of administration and in radiation 
therapy mucositis occurred after 7 to 10 days of administration, the 
incidence and severity was high in patients receiving both (Verdi. C.,2005). 
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A study was conductd to explore the relationship between oral 
mucositis and selected clinical and economic outcomes of patients with 
radiation and chemotherapy. Subjects who participated in this study 
consisted of 92 patients from eight centers. Oral mucositis scoring system 
(Oral Mucositis Assessment Scale) was used to assess oral mucositis and 
examined the relationship between patients peak oral mucositis scores and 
days with fever, the occurrence of infection, days of total parenteral 
nutrition (TPN), and days of injectable narcotic therapy, days in hospital, 
total hospital charges for the index admission, and vital status at 100 days. 
Results showed that Patients‟ peak oral mucositis scores reached the full 
range of possible values (0 to 5) and were significantly (P<0.05) correlated 
with all of the outcomes and it revealed that oral mucositis is associated 
with significantly worse clinical and economic outcomes in cancer 
treatment.( Fayed, L.,2004). 
Parulekar et al.have estimated that chemotherapy-induced 
mucositis varies from 40 to 76% in patients treated respectively with 
standard and high-dose chemotherapy. Nearly all (90% to 97%9,24) 
patients receiving radiotherapy in the head and neck will develop some 
degree of mucositis. Of these patients treated with radiotherapy with or 
without chemotherapy, 34% to 43%  presented with  severe mucositis. As a 
result, the patients quality of  life got affected, hospital admission rates are 
higher, the use of total parenteral nutrition is increased and interruption of 
treatment was more frequent, all of which compromise tumor control. 
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Mucositis causes 9% to 19% of chemotherapy and radiotherapy 
interruption. 
According to Andy Trotti et althe study protocol,  databases were 
searched for randomized clinical trials (English only, 1996–1999) of 
patients with head and neck cancer receiving RT with or without 
chemotherapy that reported one or more outcomes of interest.  Thirty-three 
studies (n=6181 patients) met inclusion criteria. Mucositis was defined 
using a variety of scoring systems. The mean incidence was 80%. Over 
one-half of patients (56%) who received altered fraction RT (RT-AF) 
experienced severe mucositis (grades 3–4) compared to 34% of patients 
who received conventional RT. Rates of hospitalization due to mucositis, 
reported in three studies (n=700), were 16% overall and 32% for RT-AF 
patients. 11% of patients had RT regimens interrupted or modified because 
of mucositis in five studies (n=1267) . Data insufficiency or heterogeneity 
prohibited analysis of mucositis severity and other associated outcomes, 
such as oral pain, dysphagia and opioid use. 
Rubina C. M.(2012) did a study on evaluation of some oral post 
radiotherapy  squeal  in patients treated for head and neck tumors. One 
hundred  patients (24 women, 76 men ) ranging in age from 30 to 83 years 
(mean 59.2 years) were examined. Time since radiotherapy ranged  from 1 
to 72 months       (mean 28 months). The total mean radiation dose  received 
by the patient was 5, 955 CGY. The evaluation protocol included  
anamnesis, intraoral and extra oral examination, measurement of stimulated 
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salivary flow and salivary PH symptoms reported by the patients included 
dry mouth (68%), dysphagia (38%) and  dysgeusia (30%). In 64% of the 
patient, the mean salivary  flow rate was less than  0.7 ml/ min.  the  mean 
salivary PH was 6.97 ( +/- o.714 ) stimulated salivary flow increased with 
increasing post radiotherapy time ( P< 0.05 ). As a conclusion the 
prevalence of mucositis was associated with higher radiation doses ( P< 
0.05 ) and the prevalence of atrophic candiadiasis was related to a longer 
post treatment period ( P < 0.05 ).  
 
2.Studiesrelated to healing of chemo and radiation related oral 
Mucositis with honey application. 
Rashad UM(2006) did a study on honey as topical prophylaxis 
against radio chemotherapy induced mucositis in head and neck cancer. The 
aim of the study is to evaluate the efficacy of pure natural honey as against 
radio chemotherapy induced mucositis. The study was done in Assiut 
university Hospital, Egypt between January 2005 and july 2006. 40 patients 
diagnosed with head and neck cancer were entered into the trial. Enrolled 
patients were randomized to either the treatment group, receiving 
concomitant chemotherapy and radiotherapy plus prior topical application 
of pure honey, or the control group, receiving concomitant chemotherapy 
and radiation therapy without honey. Patients were evaluated clinically 
every week to assess development of radiation mucositis. In the results in 
the treatment group, no patients developed grade four mecositis and only 3 
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patients (15%) developed grade three mucositis. In the control group 13 
patients (65%) developed grade three or four mucositis (p< 0.05). As a 
conclusion this study shows that prophylactic use of pure natural honey was 
effective in reducing mucositis resulting from radio chemotherapy in 
patients with head and neck cancer. 
Biswa Mohan Biswal (2003) did a study on topical application of 
honey in the management of radiation mucositis. The aim of the study was 
to evaluate the effect of pure honey on radiation induced mucositis. 40 
patients diagnosed with head and neck cancer requiring radiation to the 
oropharyngeal mucosal area were divided into two groups to receive either 
radiation alone or radiation plus topical application of pure natural honey. 
Patients were treated using a 6 mv linear accelerator at a dose rate of 2 Gy 
per day five times a week up to a dose of 60 – 70 Gy. In this study patients 
were advised to take 20 ml of pure honey 15 min before, 15 min after and 6 
hour post radiation therapy. Patients were evaluated every week for the 
development of radiation mucositis using the radiation therapy by oncology 
group ( RTOG ) grading system. The main result of the study was that there 
was significant reduction of symptomatic grade ¾ mucositis among honey – 
treated patients compared to controls. Ie, 20% vs 75% ( p 0.00058 ). The 
compliance of honey treated group of patients was better than controls. As a 
conclusion topical application of natural honey is a simple and cost- 
effective treatment in radiation mucositis. 
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Apitherapy News (2008) the aim of the study was to evaluate the 
effect of pure natural honey on radiation induced mucositis. In this 
randomized single blind (examiner blind) clinical trial 40 patients with head 
and neck cancer requiring radiation to the oropharyngeal mucosa were 
randomly assigned to two groups. Twenty patients assigned to the study 
group received honey, while both the study and control groups received 
standard head and neck radiation therapy based on a standard protocol. In 
the study group patients were instructed to take 20 ml of honey 15 minutes 
before radiation therapy, then again at the interval of 15 minutes and six 
hours after radiation. In control group patients were instructed to rinse with 
20 ml of saline before and after radiation. Patients were evaluated weekly 
for progression of mucositis using the oral mucositis assessing scale 
(OMAS). Result showed a significant reduction in mucositis among honey 
applied patients compared with control (p = o.ooo). As a conclusion with in 
the limits of this study the results showed the application of natural honey is 
effective in managing radiation induced mucositis. 
S.M. AL- Gezawy (2008)  did a study on honey as topical 
prophylaxis against radiotherapy- induced mucositis in head and neck 
cancer. The aim of the study  was to evaluate the efficacy of pure honey as 
topical prophylaxis against radiotherapy- induced mucositis, and culturing 
of pathogenic oral and oropharyngeal microbes. The study was done in 
Assiut University Hospital, Egypt, between January 2005 and july 2006. 
Forty patients diagnosed with head and neck cancer were entered in to trial. 
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Enrolled patients were randomized to either the treatment group, receiving 
concomitant chemotherapy and radiotherapy plus prior topical application 
of pure natural honey, or the control group, receiving concomitant 
chemotherapy and radiotherapy without honey. patients were evaluated 
clinically every week to assess development of radiation mucositis. Aerobic 
cultures and candida colonization assessment were undertaken, via oral and 
oropharyngeal swabs, prior to and at the completion of irradiation, and 
when infection was evident. In the result in treatment group, no patients 
developed grade four mucositis and only three patients (15%) developed 
grade three mucositis where as in the control group, 13 patients, (65%) 
developed grade three to four mucositis (p< o.o5). candida colonization was 
found in 15% of the treatment and 60% of the control group, either during 
or after radiotherapy (p= 0.003). positive cultures for aerobic pathogenic 
bacteria were observed in 15% percent of the treatment group and 65% of 
the control group, during or after radiotherapy (p=0.007). As a conclusion 
this study shows that prophylactic use of pure honey was effective in 
reducing mucositis resulting from radiotherapy in patients with head and 
neck cancer.  
Khanal (2010) did a study on anti inflammatory properities might 
limit the severity of radiation induced oral mucositis. The aim of the study 
was to assess the effect of topical honey on limitation of radiation – induced 
of mucositis. A single blind randomized, controlled clinical trial was carried 
out to compare the mucositis limiting of honey with lignocaine. A visual 
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assessment scale permitted scoring of degrees of oral mucositis and 
statistical evaluation of the results was performed using the chi square test. 
The result showed only 1patient in the honey group developed intolerable 
oral mucositis compared with the control group, indicating the honey was 
strongly protective (RR= 0.067) against the development of oral mucositis. 
The proportion of patients with intolerable oral mucositis was lower in the 
treated group and this was statiscally significant (p=0.000). As a conclusion 
application of honey topically to the oral mucosa of patients undergoing 
radiation therapy appears to provide a distinct benefit in limiting the 
severity of mucositis. 
Goyal. M et al (2009) did a study on oral mucositis  in morning vs 
evening  irradiated patients. The purpose of the study to evaluate 
prospectively the severity of acute oral mucositis in head and neck 
carcinoma  patients irradiated in the morning  ( 08.00 – 11.00h ) versus late 
afternoon/ evening ( 15.00 – 18.00h ) . A total of 212 patients of head and 
neck carcinoma were randomized to morning ( 08.00- 11.00h )  and evening 
( 15.00 – 18.00h ) groups. The grades of oral mucosa ulceration were 
compared  in two groups. The results shows the grades of mucositis were 
marginally higher in the evening irradiated group than in the  morning  
irradiated  group 38% versus 26% ( P = 0.08 ). In conclusion the observed  
incidence  of  grade III / IV mucositis  in morning vs evening irriadiated 
patients may  be because of the existence of circadian rhythm in the cell 
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cycle of normal  mucosa. This knowledge may provide a possibility of 
treating the patients with decreased toxicity to oral mucosa. 
Murphy BA (2009) did a study on mucositis related morbidity and 
resource utilization in head and neck cancer patients receiving radiation 
therapy with or without chemotherapy. The objective of this study was to 
estimate health care resource utilization in head and neck cancer (HNC) 
patients. This was a prospective, longitudinal, multicenter, 
noninterventional study of mucositis in patients receiving radiation with or 
without chemotherapy for HNC. Seventy five patients were enrolled from 
six centers – fifty ( 67% ) patients received  concurrent chemoradiation 
therapy, 34(45%) received intensity- modulated radiation therapy. Over the 
course of the treatment, 57( 76%) patients reported severe mouth and throat 
soreness pain and functional impairment because of mouth and throat 
soreness increased during the course of therapy despite the use of opoid  
analgesics in 64 ( 85% ) of the patients. As a conclusion this study 
demonstrates that mucositis related pain and functional impairment is 
associated with increased use of costly health resources .Effective 
treatments to reduce the pain and functional impairment of oral mucositis 
are needed in this patient population.  
Rose- ped, Alison M (2002) did a study on complication of radiation 
therapy for head and neck cancers, the patient perspective, personal 
interviews were conducted with 33 individuals who had received radiation 
therapy for head and neck cancers. These individuals described their 
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treatment experiences and identified the most troublesome and debilitating 
side effects of radiotherapy. Overall, lethargy and weakness, dry mouth, 
mouth sores and pain, taste changes and sore throat were the most 
frequently reported troublesome or debilitating side effects. The single most 
debilitating side effect was oropharyngeal mucositis that was characterized 
by patients as sore throat and mouth sores and pain both negatively affected 
the patients to experience significant weight loss. As a conclusion trends 
toward more aggressive management of head and neck cancers under  the 
need for new and effective therapies for oropharyngeal mucositis occurring 
in patients receiving radiotherapy. 
Renata Lazari Sandoval (2003) did a study on  Oral mucositis is a 
common complication of some malignancies treatment, causing therapeutic 
modifications due to patient's debilitation, which often interferes with the 
prognosis of the disease. Many attempts have been made to find an optimal 
treatment or preventive method to minimize the severity of oral mucositis. 
Several studies have shown good results with the use of low-energy laser, 
with the aim of accelerating the process of wound healing and promoting 
pain relief. Methods used was Patients (n=18) who developed oral 
mucositis during chemotherapy and/or radiotherapy were submitted to low-
energy laser applications until cessation of symptoms. Mucositis severity 
was scored by an oral mucositis scale based on clinical features and by an 
oral toxicity scale from the National Cancer Institute based on the ability to 
swallow; pain severity was scored by subjects on a visual analogue scale 
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before and after the applications. In result Immediate pain relief was 
achieved in 66.6% of the patients after the first application. Based on the 
functional scale, mucositis grade III (not capable to eat solids) was reduced 
in 42.85% of the cases. According to the scale based on the clinical 
features, mucositis grade IV (ulcerative lesions) was reduced in 75% of the 
patients that presented this grade of mucositis at the beginning of laser 
therapyas as a conclusionLow-energy laser was well-tolerated and showed 
beneficial effects on the management of oral mucositis, improving the 
quality of life during the oncologic treatment.  
A.P.Gautham (2012) done a study to  evaluated the effect of RK-
0202, administered as an oral rinse, on the incidence of severe oral 
mucositis in patients being treated with of radiation therapy (RT) for tumors 
of the head and neck. The method used was a prospective, randomized, 
placebo-controlled, double-blind study that compared the effect of 2 
concentrations of RK-0202 with placebo on the incidence of severe oral 
mucositis at a cumulative RT dose of 60 Gy in 110 subjects. Twenty-seven 
subjects received RK-0202 5%, 38 received RK-0202 10%, 29 received 
placebo and 16 received standard of care. Subjects began dosing just prior 
to RT and continued dosing six times daily throughout RT. Oral mucositis 
was assessed twice weekly throughout RT by trained oral evaluators.. The 
result shows the higher dose of RK-0202 (10%) successfully attenuated 
severe oral mucositis as measured by WHO or NCI-CTC v.3 criteria. The 
incidence of WHO grade 3 or 4 oral mucositis by a cumulative RT dose of 
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60 Gy was 35% in the RK-0202 group vs. 54% in the placebo group (p = 
NS). By 50 Gy the incidences in the RK-0202 and placebo groups were 
25% and 54%, respectively (p = 0.053). Similarly, the incidence of NCI 
grade 3 or 4 oral mucositis by 60 Gy was 64% in the RK-0202 cohort vs. 
92% for subjects being treated with placebo (p = 0.005). Subjects treated 
with RK-0202 required less feeding tube placement compared to placebo 
recipients (3% vs. 22%, p = 0.037) and less opiate analgesia. The median 
percent of time on opiates was 6% on RK-0202 vs. 21% on placebo. The 
overall incidence of serious adverse events was significantly lower in 
subjects treated with RK-0202 (8% vs. 31%, p = 0.024). In general, there 
was no benefit noted among subjects who received RK-0202 as a 5% 
solution. As a conclusion RK-0202 significantly reduced the incidence of 
severe mucositis in subjects treated with radiotherapy for head and neck 
cancer and was not associated with significant adverse events. 
Trotti et al (2009) performed a systematic review of the literature to 
better determine the frequency of mucositis in patients undergoing radiation 
to the head and neck. Thirty-three studies analyzing over 6100 patients were 
included. The incidence of mucositis in patients undergoing radiation was 
greater than 90% and was 100% in patients given altered fractionation. The 
overall incidence of grade 3 and 4 mucositis was 39%, with an incidence of 
57% in patients treated with altered fractionation. Although the authors 
were able to define an incidence rate of mucositis, they also highlighted 
some of the deficiencies in mucositis research. An additional finding was 
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that, despite reporting the rates of mucositis, few studies linked mucositis to 
other outcomes. Specifically, the incidence of pain, dysphagia, and 
dehydration were rarely reported. More commonly reported (64%) were 
treatment modifications, though the link to mucositis was rarely noted. As a 
conclusion Mucositis, xerostomia, and dysphagia are common effects of 
radiation. With the use of more aggressive treatment regimens the incidence 
of these effects has increased. One optimistic solution to decrease the 
incidence of these effects is the development of less toxic agents that are 
molecularly targeted to the disease without an increase in the intensity of 
effects of radiation. 
Jp Honget’al(2012) did a study on Recombinant human epidermal 
growth factor treatment of radiation-induced severe oral mucositis in 
patients with head and neck malignancies. The aim of the study was to 
evaluated the wound healing effect of human recombinant epidermal 
growth factor (rhEGF) in head and neck cancer and lymphoma patients with 
irradiation (with or without combined chemotherapy-induced oral 
mucositis). Patients at Asan Medical Center who had undergone definitive 
RT of the head and neck region with or without combined chemotherapy 
and who had developed severe oral mucositis (higher than the Radiation 
Therapy Oncology Group grade 3) were treated with topical rhEGF twice 
daily for 7 days. The evaluation of response with regard to oral mucositis 
was performed 1 week later. Of the 11 treated patients, three had 
nasopharyngeal carcinoma, three had carcinoma of the oropharynx, two had 
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carcinoma of the oral cavity, one had carcinoma of the hypopharynx and 
two had lymphoma of the head and neck. Six patients received RT only, 
and five patients received concurrent chemo radiotherapy. All patients 
showed improvements in their oral mucositis after topical treatment with 
rhEGF in that the Radiation Therapy Oncology Group grade was 
significantly decreased (P = 0.0000). As a conclusion this finding suggests 
that rhEGF is effective and safe for the treatment of radiation-induced 
mucositis. 
 
3. Studies related to healing of chemo/radiation related oral 
mucositisWith chlorhexidine mouth wash. 
A prospective randomized cross over study was conducted to 
assess the effectiveness of two oral care protocols differing in the type of 
mouthwashes. The mouthwashes used for this study were chlorhexidine 
versus benzydamine. Forty patients undergoing chemotherapy were 
allocated to receive chlorhexidine first and then benzydamine protocol. 
Subjects were evaluated in intervals of 3 to 4 days by using WHO grading 
for mucositis and 10cm visual analogue scale for oral symptom 
evaluation. The results showed that a significant difference in mean area 
of oral mucositis grade for subjects received chlorhexidine mouthwash 
compared to those received benzydamine and revealed that chlorhexidine 
may be helpful in palliating mucositis symptoms in chemotherapy(Cheng, 
K.F.,2003). 
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A randomized control trail was conducted to assess the effectiveness 
of chlorhexidine mouthwash on oral mucositis in patients receiving 
chemotherapy, total of 130 patients were participated in a clinical trial with 
pre-post design and single blind system. Subjects were divided into two 
groups using chlorhexidine mouthwash and placebo as control group. 
Patients in two groups received daily oral hygiene instructions and were 
examined daily until the mucositis heal. The results showed that mucositis 
and its related pain were disappeared after 8 to 14 days and 13 to 14 days 
respectively(Setiawan., 2004). 
 
4.Studies related to comparison of effects of other medications and 
Chlorhexidine mouth wash in healing chemo/radiation related oral 
mucositis 
Kumar,M., (2008) An experimental study was done to assess the 
effect of three alcohol-free mouthwashes on radiation-induced oral 
mucositis in patients with head and neck malignancies. Eighty patients with 
head and neck malignancies, scheduled to undergo curative radiotherapy, 
were randomly assigned to receive one of the three alcohol-free test 
mouthwashes (0.12% chlorhexidine, 1% povidone-iodine, or salt/soda) or a 
control. The patients were instructed to rinse with 10 ml of the mouthwash, 
twice a day, for a period of 6 weeks. Mucositis was assessed at baseline and 
at weekly intervals during radiation therapy, using the World Health 
Organization criteria for grading of mucositis. Among the 76 patients who 
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completed the study, patients in the povidone-iodine group had significantly 
lower mucositis scores when compared to the control group from the first 
week of radiotherapy. Their scores were also significantly lower when 
compared to the salt/soda and chlorhexidine groups from the fourth and 
fifth week, respectively, after radiotherapy. This study shows that use of 
povidone-iodine mouthwash can reduce the severity and delay the onset of 
oral mucositis due to antineoplastic radiotherapy. 
  . alla ( 2008)A study was conducted toinvestigate whether 
medicated mouthwashes are effective in the prevention of oral mucositis 
among patients undergoing chemotherapy. Randomized controlled trials 
(RCTs) on the use of mouthwashes for the treatment oral mucositis in adult 
participants undergoing chemotherapy were eligible for inclusion. The 
severity of mucositis was scored using a World Health Organization 
(WHO) instrument (or an adaptation of this scale), The instructions for use 
ranged from a 20 second rinse twice daily to a one minute rinse four times 
daily. The intervention mouthwashes were salt solution with sodium 
bicarbonate mouthwash without the active ingredient (chlorhexidine or 
chamomile), amine-stannous fluoride or water. Two authors independently 
performed the study selection. Disagreements were resolved through 
discussion with a third reviewer. Chlorhexidine mouthwash was not found 
to be more effective than control, the results do not support the use of 
chlorhexidine mouthwash in the prevention of oral mucositis, and hence the 
author concluded that the use of salt solution with sodium bicarbonate 
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rather than chlorhexidine mouthwash for the prevention of oral mucositis 
associated with chemotherapy is effective. 
A. Heydari,(2012)A clinical trial was  conducted  to evaluate the 
effectiveness of ice chips to prevent or reduce oral mucositis in patients 
treated with high doses of Alkeran. The trial included 40 patients with 
multiple myeloma. Twenty-one patients received ice chips (cryotherapy) 30 
minutes prior to treatment and continued to use the ice chips for six hours. 
Nineteen patients received normal saline instead of ice chips. Severe oral 
mucositis occurred in 14% of patients treated with ice chips, compared with 
74% of patients treated with saline. Individuals treated with ice chips 
received fewer narcotics and nutrition through a vein than those treated with 
saline.The researchers concluded that cryotherapy significantly reduces the 
incidence of severe oral mucositis in patients receiving treatment with high 
doses of Alkeran. severity P<.01, duration P=.035; cryotherapy severity 
P<.005, duration P=.003). It was pointed that while ice chips were easy and 
inexpensive to use, they are drug and schedule dependent and cannot be 
used with 5-Flurouracil infusions or with chemotherapy with long half 
lives. 
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CHAPTER III 
METHODOLOGY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Research Design 
Quasi experimental with time series pre test – post test design 
Target population 
Total cancer patients with oral mucositis due to irrespective of cycles 
Accessible population 
Patients with cancer due to chemo and radiation therapy in selected cancer center 
 
Sampling technique 
Purposive sampling technique 
Group 1 -30 cancer patients with orally 
mucositis from a 2
nd
 cycle until the last 
cycle of chemo and radiation therapy 
Group 1 -30 cancer patients with orally 
mucositis from a 2
nd
 cycle until the last 
cycle of chemo and radiation therapy 
 
Pre-test assessment of level of oral mucositis by using WHO Oral Toxicity Scale 
Post-test assessment of level of oral mucositis by using WHO Oral Toxicity Scale 
 
Introducing 5 ml of pure honey into 
the oral cavity and asking the client 
to hold it for 30 seconds for four 
times a day for four days 
Rinsing mouth and oral cavity 
with 10 ml of 2% 
chlorhexidine solution for 30 
seconds for four times a day for 
four days 
Data analysis(Descriptive and inferential statistics) 
Interpretation of findings( tables, figures and diagrams) 
Conclusion 
 
FIGURE 2.1 
SCHEMATIC REPRESENTATION OF RESEARCH METHODOLOGY 
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RESEARCH METHODOLOGY 
Methodology refers to the technique used to structure a study and to 
gather and analyze information in a systematic fashion ( Polit and Hungler, 
2003).This phase of the study includes research approach, research design, 
setting population, criteria for sample selection, sample size, sampling 
technique, development and description of tools, reliability, pilot study, data 
collection procedure and plan for data analysis. 
 
Research approach: 
According to Reverso English dictionary“Systematic investigation to 
establish facts or principles or to collect information on a subjects”. 
This study was conducted using a quantitative research approach 
compare the effects of oral honey application and chlorhexidine mouth 
wash in healing of oral mucositis among cancer patients on chemo and 
radiation in the selected hospital. 
 
Research design: 
According to Denise F. Polit (2011)“The overall plan for addressing 
a research question, including specifications for enhancing the study‟s 
integrity”. 
The research design adopted for this study was Quasi experimental 
with time series pre test post test design. It also provides great deal of 
certainty and efficiency. 
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Group Pretest Intervention Post test 
1[Honey application]Per day x 4 days O1 X1 X2 X3 X4 O2 
2[Chlorhexidine mouth wash] 
Per day x 4 days 
O1 X1 X2 X3 X4 O2 
 
O1- Assessment of oral mucositis among patients in group 1before the honey 
application  
O2- Assessment of oral mucositis among patients in group 1 after the honey 
application. 
O1- Assessment of mucositis among patients in group 2 before the chlorhexidine 
mouth wash. 
O2- Assessment of mucositis among patients in group 2 after the chlorhexidine 
mouth wash. 
X1-Administration of 5 ml of honey at 8 am in the morning.                 
X2-Administration of 5 ml of honey at 11 am in the morning.               Group 1 
X3-Administration of 5 ml of honey at 2 pm in the noon.                         ×4 days  
X4-Administration of 5 ml of honey at 5 pm in the evening. 
X1- Swishing of oral cavity with 10 ml of 0.2% chlorhexidine mouth wash  
for 30 seconds at 8 am in the morning. 
X2- Swishing of oral cavity with 10 ml of 0.2% chlorhexidine mouth wash 
for 30 seconds at 11 am in the morning.  
X3- Swishing of oral cavity with 10 ml of 0.2% chlorhexidine mouth wash   
for 30 seconds at 2 pm in the noon.                                                                    
X4- Swishing of oral cavity with 10 ml of 0.2% chlorhexidine mouth wash  
for 30 seconds at 5 pm in the evening. 
Group 2 
×4 days  
 
 
 
36 
 
Variables 
According to Denise F. Polit (2011) Variables is defined as “An 
attribute that varies, that is, takes on different values”.  
 
 Independent variables 
According to Denise F. Polit (2011) Independent variable is defined 
as “The variable that is believed to cause or influence the dependent 
variable”. 
In this study refers to the independent variables is Honey application 
and Chlorhexidine  mouth wash. 
 
 Dependent variables 
According to Denise F. Polit (2011) Dependent variable is defined as 
“The variable hypothesized to depend on or be caused by another variable 
of interest”. In this study refers to the independent variables is Oral 
mucositis 
 
SETTING OF THE STUDY 
The study was conducted in International Cancer Center, Neyyoor, 
Kanyakumari District, which is situated 15 kilometre away from Global 
College of Nursing, Nataalam, Marthandam. . It is a 100 bedded hospital for 
oncology patients. Different kind of cancer is treated with radiation and 
chemotherapy in this hospital. There is a day care centre where patients 
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come to receive chemotherapy as outpatients basics, also a separate room 
for delivering radiation therapy for  specific fractionated doses as needed 
for the patients. 
 
POPULATION 
According to Denise F. Polit (2011) A Population is defined as “The 
entire set of individuals or objects having some common characteristics”. 
The population of this study included all the cancer patients in 
2
nd
,3
rd
,or 4
th
 stage of cancer who are on chemo and radiation therapy 
admitted in International Cancer Center, Neyyoor. 
 
SAMPLE 
According to Denise F. Polit (2011) Sample is defined as, “A subset 
of a population comprising those selected to participate in a study”. 
The sample for the present study consisted of 60 cancer patients with 
oral mucositis due to Chemo/Radiation, admitted at International Cancer 
Center, Neyyoor, at Kanyakumari District. Among them 30 were allotted to 
Group 1 and 30 were allotted to Group 2.    
 
SAMPLING TECHNIQUE 
Suresh K Sharma (2007) Sampling technique is defined as, “The 
process of selecting a portion of the population to represent to the entire 
population”.  
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         In this study the investigator has intentionally selected 60 cancer 
patients with oral mucositis due to chemo and radiation therapy from the 2
nd
 
cycle until the last cycle of therapies.             
         Hence the sampling technique is purposive one. 
 
CRITERIA FOR SAMPLE SELECTION 
Inclusion criteria: 
1) Both male and female cancer patients undergoing chemotherapy / 
Radiation therapy with oral mucositis 
2) Patient from the second cycle of chemotherapy/Radiation therapy. 
3) Patients above 18 years of age 
4) Chemotherapy/ Radiation therapy patients who manifest oral mucositis 
5) Who are present during the study who are willing to participate  
 
Exclusion criteria: 
1) Patients in the first cycle of chemotherapy/Radiation therapy 
2) Patients who are critically ill. 
3) < 18 years 
4) Who are not willing to participate in the study 
5) Who are not present during the study 
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DESCRIPTION OF TOOL 
According to Denise F.Polit (2011) Instrument or Tool defined as, 
”The device used to collect data”. 
In this study the tool was developed after the extensive review of 
literature, internet search and experts advice. It was decided that the 
assessment of oral mucositis by using WHO oral toxicity scale, could be an 
appropriate tool to assess the effectiveness of oral mucositis among cancer 
patient. 
The tool developed to collect data in this study consisted into two 
sections 
 
Section A 
This section consisted of the options given for each demographic 
variables such as age, sex, frequency of mouth wash, personal habits 
duration of illness, stages of cancer   received chemotherapy, received 
radiation therapy.  
 
Section B 
The scale selected appropriately to measure the criteria of Oral 
mucositis was WHO oral toxicity scale, a standardized scale developed by 
National Cancer Institution (1999). 
 The scale consisted of four categories of manifestations which are 
treated as the basic criteria for the assessment of oral mucositis. 
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                  Grade 0- None 
                  Grade1- Soreness erythema 
                  Grade2- Erythema ulcer can eat solids 
                  Grade3- Ulcer liquid diet only 
                  Grade4- Alimentation not possible 
 
CONTENT VALIDITY 
According to Denise F. Polit (2011) Content validity defined as “The 
degree to which the items in an instrument adequately represent the 
universe of content for the concept being measured”. 
The content validity was not necessitated since the investigator has 
used a standardized criterion based measurement scale to assess the oral 
mucositis. 
 
RELIABILITY 
According to Denise F. Polit (2011) Reliability is defined as, “The 
degree of consistency or dependability with which an instrument measures 
an attribute”. 
 The reliability was assessed by using test retest method r = 0.89 
hence it was highly reliable and the tool was used in this study. 
 
ETHICAL CONSIDERATIONS 
An accumulation of values and principles that address questions of 
what is good or bad in human affairs ethics searches for acting or refaining 
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from acting for approving conduct for believing or denying something as 
out.  
This study was initiated by obtaining the written approval of 
dissertation committee of Global College of Nursing. 
A written informed consent was obtained from incharge of the 
cancer centre, Neyyoor to conduct the study. 
 
PILOT STUDY 
            According to Denise F. Polit (2011) Pilot study is defined as, “A 
small-scale version or trial run, done in preparation of a major study”. 
It is a trial rehearsal for the main study. The pilot study was conducted in 
CSI Medical Mission, Neyyoor for the period of three days. A formal 
permission was obtained from the Medical Superintend of CSI Medical 
Mission, Neyyoor.The sample size was six oral mucositis patients and they 
were selected by purposive sampling technique, three of them were allotted 
to group 1 and three in group 2. It was established with the patients and a 
brief introduction about the study was given consent was obtained from 
each subject .Reassurance was provided that the data collected would be 
kept confidential. The data relating to demographic variables were collected 
by observation checklist method. Honey was applied for treatment induced 
oral mucositis in patient with cancer in group 1 at the Concentration: 5 ml 
of honey in oral cavity for 30 seconds and then swallowing it for four times 
a day for group 1 chlorhexidine mouth wash given at the group 2 
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Concentration: Rinsing of oral cavity with 10 ml of 0.2% chlorhexidine 
solution for 30 seconds for four times a day for four days. 
       The data collected were analysed using descriptive and inferential 
statistics. The result revealed that the honey application had equal effect 
like chlorhexidine mouth wash in healing oral mucositis due to 
chemo/Radiation therapy.         
 
PROCEDURE FOR DATA COLLECTION 
The investigator selected sixty samples, thirty in group 1 and thirty 
in group 2. Using the purposive sampling technique. On selection of the 
study subject self introduction was given and verbal consent was obtained 
from the subjects and the confidentiality of the response was assured. The 
demographic data were collected from the samples selected. 
A pre test was done in both groups 1 and 2 in which the level of oral 
mucositis was assessed by using the WHO Oral Toxicity Scale. The 
researcher  then administered 5 ml of honey in oral cavity for 30 seconds 
and then swallow and for group 2 Swishing of oral cavity with 10 ml of 
0.2% chlorhexidine mouth wash solution for 30 seconds was done four 
times a day for four days. 
The investigator  assessed the effectiveness of honey application on 
the treatment induced oral mucositis in group 1 and the effectiveness of 
chlorhexidine mouth wash on oral mucositis in the group 2 using the same 
observation checklist and WHO Oral Toxicity Scale. 
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PLAN FOR DATA ANALYSIS 
The collected data were analyzed by using descriptive and inferential 
statistics . 
 
DESCRIPTIVE: 
 Statistics was used to analyse the demographic variables. 
 Frequency and percentage distribution of the demographic 
variables. 
 Frequency and percentage distribution of the pre and post test level 
of oral mucositis among group 1 and group 2. 
 
INFERENTIAL STATISTICS 
 Mean and standared deviation was used to assess the pre test and post 
test level of oral mucositis among patients in the group 1 and group 2. 
 Paired t-test was  used to compare the  pre and post test scores of oral 
mucositis between group 1 and group 2. 
 
Chi-square test was used to determine the association between the 
pre interventional level of chemotherapy induced oral mucositis among 
group I and group II with their selected demographic variables. 
Analyzed data were interpreted in tables, diagrams, graphs based on 
the findings 
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CHAPTER  IV 
DATA ANALYSIS AND INTERPRETATION 
 
The purpose of analysis was to reduce the data collected in an 
intelligible and interpretable form, using different statistical methods such 
as descriptive and inferential statistical analysis. 
 According to Polit and Hungler (2005) analysis is the method of 
organizing, sorting and scrutinizing data in such a way that research 
question can be answered. 
In this study deals with the analysis and interpretation of the 
collected data from 60 patients with oral mucositis in order to assess the 
effectiveness of honey application and chlorhexidine mouth wash, by 
comparing the pre and post test scores among  both group 1 and group 2.  
The analysis and interpretation of data were based on data collection 
and the results were computed by using descriptive (mean, frequency, 
percentage distribution and standared deviation) and inferential („t‟-test and 
chi-square test) statistics and the results were interpreted in tables, figures 
and diagrams.          
The study findings are presented in sections as follows: 
Section: 1  Description of demographic variables of patients with oral 
mucositis in group 1 and 2. 
Section: 2 Assessment of the level of oral mucositis among patient with 
Cancer due to chemo or radiation therapy in both Group 1 and 2. 
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Section: 3  Effectiveness of oral honey application on level of oral 
mucositis. Among patient with cancer due to chemo and 
radiation therapy. 
Section: 4 Effectiveness of chlorhexidine mouth wash on level of oral 
mucositis.  Among patient with cancer due to chemo and 
radiation therapy. 
Section: 5  Association between the pre test level of oral mucositis among 
patients, with cancer due to chemo and radiation therapy with 
their selected demographic variables in group 1 and group 2.  
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SECTION 1 
DESCRIPTION OF DEMOGRAPHIC VARIABLES OF PATIENT 
WITH ORAL MUCOSITIS 
Table 1.1: Frequency and percentage distribution of demographic 
variables in the  Group  1 and  2. 
 
Sl 
no 
 
 
Demographic variables 
Group 1 
[Honey 
application] 
         Group 2 
[Chlorhexidine 
mouth wash] 
F % F % 
1. Age( in years) 
a) 20-29  
b) 30-39 
c) 40-49 
d) 50-59 
e) 60-69  
 
2 
6 
8 
5 
9 
 
7 
20 
27 
17 
30 
 
5 
4 
8 
10 
3 
 
17 
13 
27 
33 
10 
2. Sex 
a) Male 
b) Female 
 
12 
18 
 
40 
60 
 
16 
14 
 
53 
47 
3. Frequency of mouth wash 
a) Once a day 
b) Twice a day 
c) Every time after 
eating 
d) Others specific 
 
4 
9 
 
17 
- 
 
13 
30 
 
57 
- 
 
3 
7 
 
20 
- 
 
10 
23 
 
67 
- 
4. Personal habits 
a) Smoking 
b) Alcoholism 
c) Betal chewing 
d) Others specify 
 
8 
14 
8 
- 
 
27 
47 
27 
- 
 
11 
15 
4 
- 
 
37 
50 
13 
- 
 
5. Stages of cancer 
a) 1st stage 
b) 2nd stage 
c) 3rd stage 
d) 4th stage 
 
0 
12 
10 
8 
 
0 
40 
33 
27 
 
0 
17 
9 
4 
 
0 
57 
30 
13 
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The above tables shows with regard to that  Age in years in  group 
1,2(7%) were in the age group of 20-29 years, 6(20%) were in the age 
group of 30-39 years,8(27%) were in the age group of 40-49 years,5(17%) 
were in the age group of 50-59 years,9(30%) were in the age group of 60-69 
years where as in the  group 2,5(17%) were in the age group of 20-29 years, 
4(13%) were in the age group of 30-39 years,8 (27%) were in the age group 
of 40-49 years,10(33%) were in the age group of 50-59 years,3(10%) were 
in the age group of 60-69 years. 
 With regard to the sex in the  group 1, 12(40%) were males and 
18(60%) were female where as in the  group 2, 16(53%) were males and 
14(47%) were females. 
6. Received chemotherapy 
per month 
a) 1-5 times 
b) 5-10 times 
c) 10-15 times 
d) Above 15 times 
 
 
13 
14 
3 
- 
 
 
43 
47 
10 
- 
 
 
16 
10 
4 
- 
 
 
53 
33 
13 
- 
7. Received  radiation 
therapy per month 
     a)   1-5 times 
     b)   5-10 times 
c)  10-15 times 
d) Above 15 times 
 
8 
15 
5 
2 
 
27 
50 
17 
7 
 
14 
10 
4 
4 
 
47 
33 
13 
13 
8. Duration of illness 
a) Less than 1 year 
b) 1-4  years 
c) 4-8 years 
d) Above 8 years 
 
12 
9 
6 
3 
 
40 
30 
20 
10 
 
14 
6 
7 
3 
 
47 
20 
23 
10 
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             Regarding frequency of mouth wash in the experimental group 1, 
4(13%) of patients taking a mouth wash once a day, 9(30%) of patient 
taking a mouth wash   twice a day, 17(57%) of patient taking mouth wash 
every time after eating. No one is taking mouth wash specifically. 
Frequency of mouth wash in the experimental group 2, 3(10%) of patients 
taking a mouth wash once a day, 7(23%) of patient taking a mouth wash 
twice a day, 20(67%) of patient taking mouth wash every time after eating. 
No one is taking mouth wash specifically. 
With regard to the personal habits in experimental group 1 8(27%) of 
patient taking smoking, 14(47%) of the patient taking alcoholism, 8(26%) 
of the patient taking betal chewing . Whereas in experimental group 2 
11(37%) of patient taking smoking, 15(50%) of the patient taking 
alcoholism, 4(13%) of the patient taking betal chewing. 
About the stages of cancer that in experimental group 1 0(0%) of 
patient in 1
st
 stage, 12(40%) of the patient in 2
nd
 stage, 10(33%) of the 
patient in 3
rd
 stage, 8(27%) 0f the patient in 4
th
 stage. Whereas in 
experimental group 2 0(0%) of patient in 1
st
 stage, 17(57%) of the patient in 
2
nd
 stage, 9(30%) of the patient in 3
rd
 stage, 4(13%) 0f the patient in 4
th
 
stage. 
Regarding the received chemotherapy in experimental group 1 
13(43%) of patient received chemotherapy 1-5 times, 14(47%) of the 
patient received chemotherapy 5-10 times, 3(10%) of patient received 
chemotherapy 10-15 times, 0(0%) of patient received chemotherapy above 
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15 times. Whereas in experimental group 2 16(53%) of patient received 
chemotherapy 1-5 times, 10(33%) of the patient received chemotherapy 5-
10 times, 4(13%) of patient received chemotherapy 10-15 times, 0(0%) of 
patient received chemotherapy above 15 times. 
With regard to the received radiation therapy in experimental group 
1 8(27%) of patient received radiation therapy 1-10 times, 15(50%) of the 
patient received radiation therapy 10-20 times, 5(17%) of patient received 
radiation therapy 20- 30times, 2(7%) of patient received radiation therapy 
above 30 times. Whereas in experimental group 2, 14(47%) of patient 
received radiation therapy 1-10 times, 10(33%) of the patient received 
radiation therapy 10-20 times, 4(13%) of patient received radiation therapy 
20- 30times, 4(13%) of patient received radiation therapy above 30 times. 
Regarding the duration of illness in experimental group 1, 12(40%) 
of patient in less than 1 year, 9(30%) of the patient in 1-4 years, 6(20%) of 
the patient in 4-8 years, 3(10%) of the patient in above 8 years. Whereas in 
experimental group 2, 14(46%) of patient in less than 1 year, 6(20%) of the 
patient in 1-4 years, 7(23%) of the patient in 4-8 years, 3(10%) of the 
patient in above 8 years. 
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Fig 3.1: Percentage distribution of samples according to age in years 
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Fig 3.2: Percentage distribution of samples according to gender in 
years 
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Fig 3.3: Percentage distribution of samples according to frequency of 
mouth wash 
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Fig 3.4: Percentage distribution of samples according to personal habits 
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Fig 3.5: Percentage distribution of samples according to stages of 
cancer 
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Fig 3.6: Percentage distribution of samples according to received 
chemotherapy 
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Fig 3.7: Percentage distribution of samples according to received 
radiation therapy 
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Fig 3.8: Percentage distribution of samples according to duration of 
illness 
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SECTION 2 
 
Table 2.1: Frequency, percentage distribution of selected subjects as 
per their  level of oral mucositis in  group 1 
Sl 
no 
 
Level of oral mucositis 
Group 1 
 
Pre test f                       
% 
Post test f                                    
% 
1 
 
2 
 
3 
 
4 
 
 5 
Grade 0 
 
Grade 1                                           
 
Grade  2                     
 
Grade  3                     
 
Grade 4 
0 
 
0 
 
0 
 
17 
 
13 
0 
 
0 
 
0 
 
57 
 
43 
20 
 
10 
 
0 
 
0 
 
0 
67 
 
33 
 
0 
 
0 
 
0 
 
The above table 2.1 shows the level of oral mucositis in the  group 1 
among patient with cancer. 
Out of 30 subjects in the group 1, 17(57%) of them had Grade 3 
level oral mucositis, 13(43%) had Grade 4 level of oral mucositis in their 
pre-test assessment. Whereas in the post-test 20(67%) of them had Grade 0, 
10(33%) had Grade 1 level of oral mucositis. 
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Table 2.2: Frequency, percentage distribution of selected subjects as 
per their level of oral mucositis in group 2 
 
Sl 
no 
Level of oral mucositis 
Group 2 
 
Pre test Post test 
f % f % 
1 
 
2 
 
3 
 
4 
 
5 
Grade 0 
 
Grade 1                                           
 
 Grade  2                     
 
Grade  3                     
 
Grade 4 
0  
 
0
 
0 
 
20 
 
10 
0 
 
0 
 
0 
 
67 
 
33 
11 
 
19 
 
0 
0 
 
0 
37 
 
63 
 
0 
0 
 
0 
 
The above table 2.2 shows the level of oral mucositis in the group 2 
among patient with cancer. 
Out of 30 subjects in the group 2, 20(67%) of them had Grade 3 
level oral mucositis, 10(33%) had Grade 4 level of oral mucositis in their 
pre-test assessment. Whereas in the post-test 11(37%) of them had Grade 0, 
19(63%) had Grade 1 level of oral mucositis. 
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Table 3.1: Comparison of pre and post test level of oral mucositis 
among patient with cancer in group 1 
Sl no Group 1 Mean SD MD ‘t’ value 
1 
 
2 
Pre test 
 
Post test 
3.5 
 
0.3 
0.489 
 
0.447 
 
3.2 
 
2.68 
      *-significant at p< 0.05 level 
 
Table 3.1 reveals that among group 1 the mean pre-test score was 3.5 
with standard deviation with 0.489. The mean post-test was 0.3 with 
standard deviation 0.447. The mean difference was 3.2. The obtained„t‟ 
value was 2.68, where as the table value was 2.04. It was significant at p< 
0.05 level. 
          It was inferred that oral honey application was highly effective in 
healing of oral mucositis among clients with cancer. 
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Fig 3.9: Comparison of pre and post test level of oral mucositis among 
patient with cancer in group 1 
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Table 3.2: Comparison of pre and post test level of oral mucositis 
among patient with cancer in group 2 
 
Sl no Experimental    Group 2 Mean SD MD ‘t’ value 
1 
 
2 
Pre test 
 
Post test 
    3.6 
 
    0.6 
   0.465 
 
   0.474 
 
   3.0 
 
  2.65* 
      *-significant at p< 0.05 level 
 
Table 3.2 reveals that among group 2 the mean pre-test score was 3.6 
with standard deviation with 0.465. The mean post-test was 0.6 with 
standard deviation 0.474. The mean difference was 3.0. The obtained „t‟ 
value was 2.65, where as the table value was 2.04. It was significant at p< 
0.05 level. 
          It was inferred that chlorhexidine mouth wash was highly effective in 
healing oral mucositis among clients with cancer. 
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Fig 3.10 Comparison of pre and post test level of oral mucositis among 
patient with cancer in group 2 
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Table 3.3: Comparison of post and post test level of oral mucositis 
among patient with cancer in group 1 and 2 
 
Sl no Group Mean SD MD ‘t’ value 
1 
 
2 
Group 1  (post test) 
 
Group 2  (post test) 
0.3 
 
0.6 
0.447 
 
0.474 
2.1 2.65* 
 *- significant at p< 0.05 level 
 
Table 3.3 reveals that  among  group 1 the mean post test score was 
0.3with standard deviation with 0.447. In the group 2 the mean post test was 
0.63, with standard deviation 0.474. The mean difference was 1.9. The 
obtained„t‟ value was 4.5, and the table value was (1.6), which was 
significant at p< 0.05 level. 
            It was inferred that oral honey application and chlohexidine mouth 
wash are effective in healing oral mucositis among clients with cancer. 
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Fig 3.11: Comparison of post and post test level of oral mucositis 
among patient with cancer in group 1 and 2 
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SECTION IV 
 Table 4.1: Association value of pre test level of oral mucositis with 
selected subjects in group 1 and 2 
n=60 
Sl 
No 
 
Demographic 
variables 
Level of oral mucositis 
χ2 
Value 
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 
f % f % f % f % f % 
1. 
 
 
 
 
 
 
 
 
 
 
2. 
Age in years 
 
       a)18-29 
 
       b) 30-41 
 
       c)42-53 
 
      d)54-65 
 
 
Sex 
 
a) Male 
 
b) Female 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
 
 
8 
 
10 
 
4 
 
5 
 
 
 
 
10 
 
19 
 
 
13 
 
17 
 
7 
 
8 
 
 
 
 
17 
 
32 
 
 
 9 
 
 8 
 
 8 
 
 8 
 
 
 
 
17 
 
14 
 
 
15 
 
13 
 
13 
 
13 
 
 
 
 
28 
 
23 
 
 
 
 
1.91 
df=12 
 
 
 
 
 
 
 
2.43 
df=4 
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3 
 
 
 
 
 
 
 
 
 
 
 
 
4. 
 
 
 
 
 
 
 
5. 
 
 
 
 
 
 
 
 
 
 
6. 
Frequency of mouth wash 
 
 
a) Once a day 
 
b) Twice a day 
 
c) Every time after eating 
 
d) Any specific 
 
 
 
Personal habits 
 
a)Smoking 
 
 b)Alcoholism 
 
c)Betal chewing 
 
Stages of cancer 
 
a)1
st
 stage 
 
b)2
nd
 stage 
 
c)3
rd
 stage 
 
d)4
th
 stage 
 
 
Received chemotherapy 
 
a)1-5 times 
 
b)5-10 times 
 
c)10-15 times 
 
d)Above15 times  
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
4 
 
10 
 
13 
 
0 
 
 
 
 
 
9 
 
14 
 
4 
 
 
 
0 
 
15 
 
9 
 
3 
 
 
 
 
11 
 
9 
 
5 
 
2 
 
 
 
7 
 
17 
 
22 
 
0 
 
 
 
 
 
15 
 
23 
 
7 
 
 
 
0 
 
25 
 
15 
 
5 
 
 
 
 
18 
 
15 
 
 8 
 
3 
 
 
 
6 
 
7 
 
20 
 
0 
 
 
 
 
 
11 
 
18 
 
4 
 
 
 
0 
 
15 
 
12 
 
6 
 
 
 
 
15 
 
12 
 
4 
 
2 
 
 
 
10 
 
12 
 
33 
 
 0 
 
 
 
 
 
18 
 
30 
 
7 
 
 
 
0 
 
25 
 
20 
 
10 
 
 
 
 
25 
 
20 
 
7 
 
3 
 
 
 
 
 
1.78 
  
df=12 
 
 
 
 
 
 
 
 
 
0.08 
df=8 
 
 
 
 
 
 
 
0.81 
df=12 
 
 
 
 
 
 
 
 
 
0.51 
df=12 
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7. 
 
 
 
 
 
 
 
 
 
 
 
8. 
Received radiation 
therapy 
 
a)1-10 times 
 
b)10-20 times 
 
c)20-30 times 
 
d)Above 30 times 
 
 
Durationof illness 
 
a)Less than 1 year 
 
b)1-4 years 
 
c)4-8 years 
 
d)Above 8 years 
 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
 
0 
 
0 
 
0 
 
0 
 
 
 
10 
 
6 
 
8 
 
3 
 
 
 
 
4 
 
14 
 
6 
 
3 
 
 
 
17 
 
10 
 
13 
 
5 
 
 
 
 
7 
 
23 
 
10 
 
5 
 
 
 
7 
 
12 
 
5 
 
9 
 
 
 
 
8 
 
15 
 
8 
 
2 
 
 
 
12 
 
20 
 
8 
 
15 
 
 
 
 
13 
 
25 
 
13 
 
3 
 
 
 
 
 
 
  5.62 
df=12 
 
 
 
 
 
 
 
 
 
 7.42 
df=12 
*- significant at P<0.05 level    df = degree of freedom 
 
Table 4.1 indicates the sustentative summary of chi-square analysis, 
which was used to bring out the association between the level of oral 
mucositis and their selected demographic variables. 
With regard to age, 8(13%) were 18-29 years of age experienced 
grade 3 level of oral mucositis, and 9(15%) experienced grade 4 level of 
oral mucositis. 10(17%) were 30-41 years  of age experienced grade 3 level 
of oral mucositis, and 8(13%) experienced grade 4 level of oral 
mucositis.4(7%) were 42-53 years  of age experienced grade 3 level of oral 
mucositis and 8(13%) experienced grade 4 level of oral mucositis. 5(8%) 
were 54-65 years of age experienced grade 3 level of oral mucositis, and 
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8(13%) experienced grade 4 level of oral mucositis . The obtained chi-
square value was 1.91 which is statistically not significant at p < 0.05 level. 
With regard to Gender, among male 10(17%) were experienced 
grade 3 level of oral mucositis and 17(28%) experienced grade 4 level of 
oral mucositis. Gender, among female 19(32%) were experienced grade 3 
level of oral mucositis and 14(23%) experienced grade 4 level of oral 
mucositis. The obtained chi-square value was 2.43 which is statistically not 
significant at p < 0.05 level. 
 With regard to the frequency of mouth wash, among Once a day 
4(7%) experienced  grade 3 level of oral mucositis and 6(10%) experienced 
grade 4 level of oral mucositis. Frequency of mouth wash, among Twice a 
day 10(17%) experienced  grade 3 level of oral mucositis and 7(12%) 
experienced grade 4 level of oral mucositis. Frequency of mouth wash, 
among Every time after eating 13(22%) experienced grade 3 level of oral 
mucositis and 20(33%) experienced grade 4 level of oral mucositis. The 
obtained chi-square value was 1.78, which was statistically not significant 
at P<0.05 level. 
 With regard to the personal habits, among Smoking 9(15%) 
experienced  grade 3 level of oral mucositis and 11(18%) experienced grade 
4 level of oral mucositis. Personal habits among Alcoholism 14(23%) 
experienced grade 3 level of oral mucositis and 18(30%) experienced grade 
4 level of oral mucositis. Personal habits among Betal chewing 4(7%) 
experienced grade 3 level of oral mucositis and 4(7%) experienced grade 4 
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level of oral mucositis. The obtained chi-square value was 0.08, which was 
statistically not significant at P<0.05 level. 
With regard to the stages of cancer, among 2
nd
stage of cancer 
15(25%) experienced  grade 3 level of oral mucositis and 15(25%) 
experienced grade 4 level of oral mucositis. Stage of cancer, among  3
rd
 
stage of cancer 9(15%) experienced  grade 3 level of oral mucositis and 
12(20%) experienced grade 4 level of oral mucositis. Stage of cancer, 
among 4
th
 stage of cancer 3(5%) experienced grade 3 level of oral mucositis 
and 6(10%) experienced grade 4 level of oral mucositis. The obtained chi-
square value was 0.81, which was statistically not significant at P<0.05 
level. 
 With regard to Received chemotherapy, regarding the clients 
receiving 1-5 times of chemotherapy 11(18%) experienced grade 3 level of 
oral mucositis and 15(25%) experienced grade 4 level of oral mucositis. 
Clients receiving 5-10 times of chemotherapy 9(15%) experienced grade 3 
level of oral mucositis and 12(20%) experienced grade 4 level of oral 
mucositis. Clients receiving 10-15 times of chemotherapy 5(8%) 
experienced grade 3 level of oral mucositis and 4(7%) experienced grade 4 
level of oral mucositis. Clients receiving Above 15 times of chemotherapy 
2(3%) experienced grade 3 level of oral mucositis and 2(3%) experienced 
grade 4 level of oral mucositis. The obtained chi-square value was 0.51, 
which was statistically not significant at P<0.05 level. 
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With regard to Received radiation therapy, regarding the clients 
receiving 1-10 times of radiation therapy 10(17%) experienced grade 3 
level of oral mucositis and 7(12%) experienced grade 4 level of oral 
mucositis. Clients receiving 10-20 times of radiation therapy 6(10%) 
experienced grade 3 level of oral mucositis and 12(20%) experienced grade 
4 level of oral mucositis. Clients receiving 20-30 times of radiation therapy 
8(13%) experienced grade 3 level of oral mucositis and 5(8%) experienced 
grade 4 level of oral mucositis. Clients receiving Above 30 times of 
radiation therapy 3(5%) experienced grade 3 level of oral mucositis and 
9(15%) experienced grade 4 level of oral mucositis. The obtained chi-
square value was 5.62, which was statistically not significant at P<0.05 
level. 
 With regard to the duration of illness, among clients suffering less 
than 1 year 4(7%) experienced  grade 3 level of oral mucositis and 8(13%) 
experienced grade 4 level of oral mucositis . Clients suffering between 1 – 4 
years, 14(23%) were experienced grade 3 level of oral mucositis and 
15(25%) experienced grade 4 level of oral mucositis. Clients suffering 
between 4 – 8 years, 6(10%) were experienced grade 3 level of oral 
mucositis and 8(13%) experienced grade 4 level of oral mucositis. Clients 
suffering Above 8 years, 3(5%) were experienced grade 3 level of oral 
mucositis and 2(3%) experienced grade 4 level of oral mucositis. The 
obtained chi-square value was 7.42, which was statistically not significant 
at P<0.05 level 
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CHAPTER V 
DISCUSSION 
The main aim of the study was to compare the effects of oral honey 
application and chlorhexidine mouth wash in healing of oral mucositis 
among cancer patients on chemo and radiation  therapy. The study was 
conducted by using quasi experimental design with  time.  
Series pre and post test with group 1 and Group 2. The present study 
was conducted in Kanyakumari Medical Mission CSI- International Cancer 
Center at Neyyoor. The sampling technique is Purposive Sampling 
technique was used for this study. The total sample size was 60, among 
them 30 were in the group 1 and 30 were in the  group 2. WHO Oral 
Toxicity Scale was used for data collection. After data collection, data was 
organized, tabulated, summarized and analyzed. The study findings were 
discussed in this chapter with reference to the objectives of the study.  
 
OBJECTIVES 
1. To assess the  level of  oral mucositis  due to chemo /radiation 
therapy  in patient with cancer among Groups 1 and 2. 
2. To assess the post test level of  oral mucositis after oral application 
of honey for group 1 and chlorhexidine mouth wash  for group 2. 
3. To assess the effect of oral honey application in healing oral 
mucositis due to chemo/radiation  by comparing the pre and post test 
scores within group 1  . 
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4. To assess the effect of chlorhexidine mouth wash in healing oral 
mucositis due to chemo/radiation  by comparing the pre and post test 
scores within group 1  . 
5. To compare the effects of oral honey application and chlorhexidine  
mouth wash in healing oral mucositis due to chemo/radiation 
6. To determine the association between  the pretest level of oral 
mucositis due to chemo/radiation among groups 1 and 2 and their 
selected demographic variables such as age, gender, frequency of 
mouth wash, personal habits, duration of illness, stages of cancer, 
received chemotherapy, received radiation therapy. 
 
The first objective of this study was to assess the level of oral mucositis  
due to chemo radiation therapy in patient with cancer among Groups 1 
and 2. 
Out of 30 subjects in the experimental group 1, 17(57%) of them had 
Grade 3 level oral mucositis, 13(43%) had Grade 4 level of oral mucositis 
in their pre-test assessment. Whereas in the post-test 20(67%) of them had 
Grade 0, 10(33%) had Grade 1 level of oral mucositis. 
Out of 30 subjects in the experimental group 2, 20(67%) of them had 
Grade 3 level oral mucositis, 10(33%) had Grade 4 level of oral mucositis 
in their pre-test assessment. Whereas in the post-test 11(37%) of them had 
Grade 0, 19(63%) had Grade 1 level of oral mucositis. 
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           Parulekar et al.have estimated that chemotherapy-induced mucositis 
varies from 40 to 76% in patients treated respectively with standard and 
high-dose chemotherapy. Nearly all (90% to 97%9,24) patients receiving 
radiotherapy in the head and neck will develop some degree of mucositis. 
Of these patients treated with radiotherapy with or without chemotherapy, 
34% to 43% will present severe mucositis. As a result, the patients quality 
oflife is affected, hospital admittance rates are higher, the use of total 
parenteral nutrition is increased and interruption of treatment is more 
frequent, all of which compromise tumor control. Mucositis causes 9% to 
19% of chemotherapy and radiotherapy interruption. 
 
The second objective of this study was to assess the post test level of  
oral mucositis after oral application of honey for group 1 and 
chlorhexidine mouth wash  for group 2. 
It reveals that among experimental group 1 the mean pre-test score 
was 3.5 with standard deviation with 0.489. The mean post-test was 0.3 
with standard deviation 0.447. The mean difference was 1.11. The 
obtained„t‟ value was 2.68, where as the table value was 2.04. It was 
significant at p< 0.05 level. 
It was inferred that oral honey application was highly effective in 
healing of oral mucositis among clients with cancer 
Rashad UM (2006) did a study on honey as topical prophylaxis against 
radio chemotherapy induced mucositis in head and neck cancer. The aim 
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of the study is to evaluate the efficacy of pure natural honey as against 
radio chemotherapy induced mucositis. The study was done in Assiut 
university Hospital, Egypt between January 2005 and july 2006. 40 
patients diagnosed with head and neck cancer were entered into the trial. 
Enrolled patients were randomized to either the treatment group, 
receiving concomitant chemotherapy and radiotherapy plus prior topical 
application of pure honey, or the control group, receiving concomitant 
chemotherapy and radiation therapy without honey. Patients were 
evaluated clinically every week to assess development of radiation 
mucositis. In the results in the treatment group, no patients developed 
grade four mecositis and only 3 patients (15%) developed grade three 
mucositis. In the control group 13 patients (65%) developed grade three 
or four mucositis ( p< 0.05 ). As a conclusion this study shows that 
prophylactic use of pure natural honey was effective in reducing 
mucositis resulting from radio chemotherapy in patients with head and 
neck cancer. 
It reveals that among experimental group 2 the mean pre-test score 
was 3.6 with standard deviation with 0.465. The mean post-test was 0.6 
with standard deviation 0.474. The mean difference was 1.11. The obtained 
„t‟ value was 2.65, where as the table value was 2.04. It was significant at 
p< 0.05 level. 
          It was inferred that chlorhexidine mouth wash was highly effective in 
healing oral mucositis among clients with cancer. 
 
 
 
76 
 
           The findings of the study was supported byRV.Lalla ( 2008) A study 
was conducted toinvestigate whether medicated mouthwashes are effective 
in the prevention of oral mucositis among patients undergoing 
chemotherapy. Randomized controlled trials (RCTs) on the use of 
mouthwashes for the treatment oral mucositis in adult participants 
undergoing chemotherapy were eligible for inclusion. The severity of 
mucositis was scored using a World Health Organization (WHO) 
instrument (or an adaptation of this scale), The instructions for use ranged 
from a 20 second rinse twice daily to a one minute rinse four times daily. 
The intervention mouthwashes were salt solution with sodium bicarbonate 
mouthwash without the active ingredient (chlorhexidine or chamomile), 
amine-stannous fluoride or water. Two authors independently performed 
the study selection. Disagreements were resolved through discussion with a 
third reviewer. Chlorhexidine mouthwash was not found to be more 
effective than control, the results do not support the use of chlorhexidine 
mouthwash in the prevention of oral mucositis, and hence the author 
concluded that the use of salt solution with sodium bicarbonate rather than 
chlorhexidine mouthwash for the prevention of oral mucositis associated 
with chemotherapy is effective. 
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The third objective of this study to assess the effect of oral honey 
application in healing oral mucositis due to chemo/radiation  by 
comparing the  post test scores within group 1 and group 2. 
It reveals that among experimental group 1 the mean post test score 
was 0.3with standard deviation with 0.447. In the experimental group 2 the 
mean post test was 0.63, with standard deviation 0.474. The mean 
difference was 1.9. The obtained„t‟ value was 4.5, and the table value was 
(1.6), which was significant at p< 0.05 level. 
            It was inferred that oral honey application and chlohexidine mouth 
wash are effective in healing oral mucositis among clients with cancer. 
The effectiveness of commonly used mouthwashes for the 
prevention and treatment of chemotherapy-induced oral mucositis: a 
systematic review of daily chlorhexidine mouthwash was often 
recommended for preventing chemotherapy-induced oral mucositis. 
Povidone-iodine, NaCl 0.9%, water salt soda solution and chamomile 
mouthwash were also recommended. However, the effectiveness of these 
mouthwashes was unclear. A systemic review was conducted to assess the 
effectiveness of mouthwashes in preventing and treating chemotherapy-
induced oral mucositis. Based on study quality, three out of five 
randomized controlled trials were included in a meta-analysis. The results 
failed to detect any beneficial effects of chlorhexidine as compared with 
sterile water, or NaCl 0.9%. The severity of oral mucositis was shown to be 
reduced by 30% using a povidone-iodine mouthwash as compared with 
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sterile water in a single randomized controlled trial. These results do not 
support the use of chlorhexidine mouthwash to prevent and treat oral 
mucositis. (Potting,C., 2006). 
 
The forth objective to determine the association between the pretest 
level of oral mucositis due to chemo/radiation among groups 1 and 2. 
Indicates the sustentative summary of chi-square analysis, which was 
used to bring out the association between the level of oral mucositis and 
their selected demographic variables. 
With regard to age, 8(13%) were 18-29 years of age experienced 
grade 3 level of oral mucositis, and 9(15%) experienced grade 4 level of 
oral mucositis. 10(17%) were 30-41 years  of age experienced grade 3 level 
of oral mucositis, and 8(13%) experienced grade 4 level of oral mucositis 
.4(7%) were 42-53 years  of age experienced grade 3 level of oral mucositis 
and 8(13%) experienced grade 4 level of oral mucositis. 5(8%) were 54-65 
years of age experienced grade 3 level of oral mucositis, and 8(13%) 
experienced grade 4 level of oral mucositis . The obtained chi-square value 
was 1.91 which is statistically not significant at p < 0.05 level. 
With regard to Gender, among male 10(17%) were experienced 
grade 3 level of oral mucositis and 17(28%) experienced grade 4 level of 
oral mucositis. Gender, among female 19(32%) were experienced grade 3 
level of oral mucositis and 14(23%) experienced grade 4 level of oral 
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mucositis. The obtained chi-square value was 2.43 which is statistically not 
significant at p < 0.05 level. 
 With regard to the frequency of mouth wash, among Once a day 
4(7%) experienced  grade 3 level of oral mucositis and 6(10%) experienced 
grade 4 level of oral mucositis. Frequency of mouth wash, among Twice a 
day 10(17%) experienced  grade 3 level of oral mucositis and 7(12%) 
experienced grade 4 level of oral mucositis. Frequency of mouth wash, 
among Every time after eating 13(22%) experienced grade 3 level of oral 
mucositis and 20(33%) experienced grade 4 level of oral mucositis. The 
obtained chi-square value was 1.78, which was statistically not significant 
at P<0.05 level. 
With regard to the personal habits, among Smoking 9(15%) 
experienced  grade 3 level of oral mucositis and 11(18%) experienced grade 
4 level of oral mucositis. Personal habits among Alcoholism 14(23%) 
experienced grade 3 level of oral mucositis and 18(30%) experienced grade 
4 level of oral mucositis. Personal habits among Betal chewing 4(7%) 
experienced grade 3 level of oral mucositis and 4(7%) experienced grade 4 
level of oral mucositis. The obtained chi-square value was 0.08, which was 
statistically not significant at P<0.05 level. 
With regard to the stages of cancer, among 2
nd
stage of cancer 
15(25%) experienced  grade 3 level of oral mucositis and 15(25%) 
experienced grade 4 level of oral mucositis. Stage of cancer, among 3
rd
 
stage of cancer 9(15%) experienced  grade 3 level of oral mucositis and 
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12(20%) experienced grade 4 level of oral mucositis. Stage of cancer, 
among 4
th
 stage of cancer 3(5%) experienced grade 3 level of oral mucositis 
and 6(10%) experienced grade 4 level of oral mucositis. The obtained chi-
square value was 0.81, which was statistically not significant at P<0.05 
level. 
 With regard to Received chemotherapy, regarding the clients 
receiving 1-5 times of chemotherapy 11(18%) experienced grade 3 level of 
oral mucositis and 15(25%) experienced grade 4 level of oral mucositis. 
Clients receiving 5-10 times of chemotherapy 9(15%) experienced grade 3 
level of oral mucositis and 12(20%) experienced grade 4 level of oral 
mucositis. Clients receiving 10-15 times of chemotherapy 5(8%) 
experienced grade 3 level of oral mucositis and 4(7%) experienced grade 4 
level of oral mucositis. Clients receiving Above 15 times of chemotherapy 
2(3%) experienced grade 3 level of oral mucositis and 2(3%) experienced 
grade 4 level of oral mucositis. The obtained chi-square value was 0.51, 
which was statistically not significant at P<0.05 level 
             With regard to Received radiation therapy, regarding the clients 
receiving 1-10 times of radiation therapy 10(17%) experienced grade 3 
level of oral mucositis and 7(12%) experienced grade 4 level of oral 
mucositis. Clients receiving 10-20 times of radiation therapy 6(10%) 
experienced grade 3 level of oral mucositis and 12(20%) experienced grade 
4 level of oral mucositis. Clients receiving 20-30 times of radiation therapy 
8(13%) experienced grade 3 level of oral mucositis and 5(8%) experienced 
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grade 4 level of oral mucositis. Clients receiving Above 30 times of 
radiation therapy 3(5%) experienced grade 3 level of oral mucositis and 
9(15%) experienced grade 4 level of oral mucositis. The obtained chi-
square value was 5.62, which was statistically not significant at P<0.05 
level. 
With regard to the duration of illness, among clients suffering less 
than 1 year 4(7%) experienced  grade 3 level of oral mucositis and 8(13%) 
experienced grade 4 level of oral mucositis . Clients suffering between 1 – 4 
years, 14(23%) were experienced grade 3 level of oral mucositis and 
15(25%) experienced grade 4 level of oral mucositis. Clients suffering 
between 4 – 8 years, 6(10%) were experienced grade 3 level of oral 
mucositis and 8(13%) experienced grade 4 level of oral mucositis. Clients 
suffering Above 8 years, 3(5%) were experienced grade 3 level of oral 
mucositis and 2(3%) experienced grade 4 level of oral mucositis. The 
obtained chi-square value was 7.42, which was statistically not significant 
at P<0.05 level.                          
 
 
 
 
 
  
 
 
 
82 
 
CHAPTER VI 
SUMMARY, CONCLUSION AND RECOMMENDATIONS 
 
This chapter deals with summary, conclusion, limitation and 
recommendation of the study. Further it includes implications for the 
Nursing Practice, Nursing Education, Nursing Administration and Nursing 
Research. 
 
Summary of the Study 
The aim of the study was to compare the effects of oral honey 
application and chlorhexidine mouth wash in healing of oral mucositis 
among cancer patients on chemo and  radiation  in the selected hospital at 
Kanyakumari district. 
 The objectives of the study were 
1) To assess the level of oral mucositis due to chemo /radiation therapy 
in patient with cancer among Groups 1 and 2. 
2) To assess the post test level of  oral mucositis after oral application of 
honey for group 1 and chlorhexidine mouth wash  for group 2. 
3) To assess the effect of oral honey application in healing oral mucositis 
due to chemo/radiation  by comparing the pre and post test scores 
within group 1. 
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4) To assess the effect of chlorhexidine mouth wash in healing oral 
mucositis due to chemo/radiation by comparing the pre and post test 
scores within group 1. 
5) To compare the effects of oral honey application and chlorhexidine  
mouth wash in healing oral mucositis due to chemo/radiation. 
6) To determine the association between  the pretest level of oral 
mucositis due to chemo/radiation among groups 1 and 2 and their 
selected demographic variables 
A quasi experimental with time series pre test post test design was 
chosen for this study.  Purposive sampling technique was used for this 
study. Subjects were selected based upon the inclusion and exclusion 
criteria. 60 subjects were selected for the study. Purposively 30 Subjects 
were assigned to the group 1 and 30 subjects were assigned to the group 2. 
The tool used to collect the data consisted of two parts, Part I: 
consisted of demographic Variables with age, gender, education, 
occupation, stage of cancer, duration of illness, duration of treatment, 
modality of treatment and number of radiation cycles. Part II consisted of 
WHO Oral Toxicity Scale to assess the level of oral mucositis among 
patients with cancer. 
        Reliability of the tool was calculated by using test-retest method(r 
=0.89). Data collection was done for 4 weeks. Samplewere selected based 
on the inclusion and exclusion criteria. Pre test was done by using 
demographic variables and WHO oral toxicity scale on day one. 
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Introducing 5 ml of pure honey into the oral cavity and asking the client to 
hold it for 30 seconds until it spread over and  then swallowing it, thus it is 
done four times a day group 1 and  rinsing mouth and  oral cavity with 10 
ml of  0.2% chlorhexidine  solution for 30 seconds  for four times a day in 
group 2. 
 After the oral honey application and chlorhexidine mouth wash 
intervention post test was done. Collected data was analyzed by both 
descriptive statistics (mean, standard deviation, frequency and percentage) 
and inferential statistics (dependent and independent„t‟ test, chi-square) and 
results were calculated. 
 
Major Findings of the Study 
With regard to the level of oral mucositis among patients with 
cancer, most of them are under Grade 3 and Grade 4 level of oral mucositis. 
On post test assessment it revealed that the subjects showed reduction in 
level of oral mucositis from Grade 4 to Grade 2 and Grade 3 to Grade 1 
level of oral mucositis. 
It reveals that among experimental group 1 the mean pre-test score 
was 3.5 with standard deviation with 0.489. The mean post-test was 0.3 
with standard deviation 0.447. The mean difference was 1.11. The 
obtained„t‟ value was 2.68, where as the table value was 2.04. It was 
significant at p< 0.05 level. 
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It was inferred that oral honey application was highly effective in 
healing of oral mucositis among clients with cancer. 
It reveals that among experimental group 2 the mean pre-test score 
was 3.6 with standard deviation with 0.465. The mean post-test was 0.6 
with standard deviation 0.474. The mean difference was 1.11. The obtained 
„t‟ value was 2.65, where as the table value was 2.04. It was significant at 
p< 0.05 level. 
It was inferred that chlorhexidine mouth wash was highly effective 
in healing oral mucositis among clients with cancer. 
With regard to the association between the level of oral mucositis 
and selected demographic variables in  group 1 and group 2. The study 
findings have revealed that in post test in the group 1 there was a significant 
association between duration of treatment, where as in the group 2 there 
was a significant association between oral mucositis and received chemo  
and radiation therapy. 
 
Conclusion 
The main conclusion of the present study is oral honey application 
and chlorhexidine mouth wash both are effective in reducing oral mucositis 
among patients with cancer which is denoted by significant level of oral 
mucositis. After the intervention there had been a significant reduction in 
level of oral mucositis. The selected subjects became familiar and found 
themselves comfortable and also expressed satisfaction. 
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Implication of the Study 
Nursing implication includes specific information for Nursing 
practice, Nursing Education, Nursing Administration and Nursing research. 
Nursing implication for this study is 
 
Nursing Practice   
 Oral honey application and chlorhexidine mouth wash for oral 
mucositis management can be included as nursing procedure to 
provide care for patients with cancer with oral mucositis. 
 Oral honey application and chlorhexidine mouth wash is considered 
as experimental study and can be imparted to nursing students to 
improve skill in providing care and update their knowledge on 
evidence based practice. 
 Regular health education program can be conducted in the 
oncological units by nursing Personnel to help the patients with 
cancer in reducing the level of oral mucositis. 
 Nurses are in best position to oral honey application and 
chlorhexidine mouth wash  the patients with cancer related oral 
mucositis in oncological units and in the community. 
 Nurses play an important role in primary health care by early 
detection and prevention of oral mucositis. Oral honey application 
and chlorhexidine mouth wash can be used as a means of health 
 
 
 
87 
 
promotion on level of oral mucositis among patients with cancer 
receiving cancer treatments. 
 
Nursing Education 
 Nurses could learn the assessment of oral mucositis and given oral 
honey application and chlorhexidine mouth wash in reducing oral 
mucositis among patients with cancer as a independent nursing 
intervention. 
 Nursing students should be taught about the importance of oral 
honey application and chlorhexidine mouth wash thereby they can 
help patients with cancer to overcome oral mucositis. 
 Adequate practical training can be given to the nursing staff and 
students regarding oral honey application and chlorhexidine mouth 
wash in reduction of oral mucositis and can be incorporated in 
nursing curriculum. 
 
Nursing Administration 
 The Nurse administrators can initiate oral honey application and 
chlorhexidine mouth wash to reduce the oral mucositis through 
developmental programme like in-service education and continuing 
nursing education programme. 
 Nurse administrators can prepare written policies and protocols 
regarding care of oral mucositis. 
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Nursing Research 
 The nurse researcher can conduct many studies in different 
experimental study to bring about newer perspective in nursing care. 
 The study finding will motivate the initial researchers to conduct the 
same study on large scale and study will be the reference for the 
extensive and intensive nursing care.  
 
Recommendations 
 A similar study can be replicated on a large sample size. 
 A similar study can be conducted in different settings. 
 A similar study can be done with other intervention to reduce oral 
mucositis. 
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APPENDIX –I 
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APPENDIX –II 
TOOLS FOR DATA COLLECTION 
Section- A: Demographic variables 
        Sample No: 
Date: ……………… 
Demographic data: 
1. Age (in years) 
  a)  20 - 29         (    ) 
 b)  30 - 39                               (    ) 
c)   40 - 49        (    ) 
            d)   50 – 59                                                                                          (    ) 
            e)   60 – 69                                                                                          (    ) 
2. Sex  
  a) Male        (    ) 
   b)  Female        (    ) 
3. Frequency of self mouth wash 
              a) Once a day                                                                                    (    ) 
              b) Twice a day                                                                                  (    ) 
              c) Every time after eating                                                                 (    ) 
              d) Others-specify                                                                              (    ) 
4. Personal habits 
               a) Smoking                                                                                       (    ) 
               b) Alcoholism                                                                                  (    ) 
               c) Betal chewing                                                                              (    ) 
              d) Others specify                                                                              (     ) 
 
iii 
5. Stages of cancer 
               a) 1
st
 stage                                                                                      (    ) 
               b) 2
nd
 stage                                                                                     (    ) 
               c) 3
rd
 stage                                                                                      (    ) 
               d) 4
th
 stage                                                                                      (    ) 
6. Received chemotherapy 
               a) 1-5 times                                                                                     (    )    
               b) 5-10 times                                                                                   (    ) 
               c) 10-15 times                                                                                 (    ) 
               d) Above 15 times                                                                           (    ) 
7. Received radiation therapy 
               a) 1-5 times                                                                                     (    )    
               b) 5-10 times                                                                                   (    ) 
               c) 10-15 times                                                                                 (    ) 
               d) Above 15 times                                                                           (    ) 
8. Duration of illness 
              a) Less than 1 year                                                                           (    ) 
              b) 1-4 years                                                                                      (    ) 
              c) 4-8 years                                                                                      (    ) 
              d) Above 8 years                                                                              (    ) 
 
                         
 
 
 
iv 
Section –B: WHO Oral Toxicity Scale 
 
WHO Oral Toxicity Scale developed by National Cancer Institution (1999) 
the tool was use to assess the oral mucositis 
   
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 
     None Soreness      
erythema 
Erythema 
ulcer can eat 
solids 
Ulcer liquid 
diet only 
Alimentation 
not possible 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
Section -C : Intervention 
 
Oral honey application: 
              5 ml of honey in oral cavity for 30 seconds and then swallowing it 
for four times a day for group 1  
 Administration of 5 ml of honey at 8 am in the morning.                 
 Administration of 5 ml of honey at 11 am in the morning.               
 Administration of 5 ml of honey at 2 pm in the noon.                       
 Administration of 5 ml of honey at 5 pm in the evening. 
 
Chlorhexidine mouth wash: 
Rinsing of oral cavity with 10 ml of 0.2% chlorhexidine solution for 
30 seconds for four times a day for four days. 
 Swishing of oral cavity with 10 ml of 0.2% chlorhexidine mouth 
wash for 30 seconds at 8 am in the morning. 
 Swishing of oral cavity with 10 ml of 0.2% chlorhexidine mouth 
wash for 30 seconds at 11 am in the morning. 
 Swishing of oral cavity with 10 ml of 0.2% chlorhexidine mouth 
wash  for 30 seconds at 2 pm in the noon.    
 Swishing of oral cavity with 10 ml of 0.2% chlorhexidine mouth 
wash for 30 seconds at 5 pm in the evening. 
 
